Rockefeller University

Digital Commons @ RU
Student Theses and Dissertations

2010

Genome-Wide Decoding of mRNP and miRNA
Maps
Sung Wook Chi

Follow this and additional works at: http://digitalcommons.rockefeller.edu/
student_theses_and_dissertations
Part of the Life Sciences Commons
Recommended Citation
Chi, Sung Wook, "Genome-Wide Decoding of mRNP and miRNA Maps" (2010). Student Theses and Dissertations. Paper 90.

This Thesis is brought to you for free and open access by Digital Commons @ RU. It has been accepted for inclusion in Student Theses and
Dissertations by an authorized administrator of Digital Commons @ RU. For more information, please contact mcsweej@mail.rockefeller.edu.

GENOME‐WIDE DECODING OF MRNP AND MIRNA MAPS

A Thesis Presented to the Faculty of
The Rockefeller University
in Partial Fulfillment of the Requirements for
the degree of Doctor of Philosophy

by
Sung Wook Chi
June 2010

© Copyright by Sung Wook Chi 2010

Genome-wide decoding of mRNP and miRNA maps

Sung Wook Chi, Ph.D.
The Rockefeller University 2010

The limited number of primary transcripts in the genome has promoted interest
in the possibility that much of the complexity in the regulation of gene
expression may be determined by RNA regulation controlled by RNA-binding
proteins

(RNABPs)

and/or

microRNAs

(miRNAs).

However,

applying

biochemical methods to understand such interactions in living tissues is major
challenge. Here we developed a genome-wide means of mapping messenger
ribonucleoprotein (mRNP) sites in vivo, by high-throughput sequencing of RNA
isolated by crosslinking immunoprecipitation (HITS-CLIP). HITS-CLIP analysis
of the neuron-specific splicing factor Nova provides genome-wide maps of
Nova-RNA interactions in vivo and leads to a new finding that Nova may
regulate the processesing of some miRNAs. Furthermore, HITS-CLIP analysis is
extended to the problem of identifying miRNA targets, for which prediction is a
major challenge since miRNA activity requires base pairing through only 6-8
“seed” nucleotides. By generating crosslinking of native Argonaute (Ago)
protein-RNA complexes in mouse brain, Ago HITS-CLIP produced two
simultaneous datasets—Ago-miRNA and Ago-mRNA binding sites—that were
combined with bioinformatic analysis to identify miRNA-target mRNA
interaction sites. We validated genome-wide interaction maps for miR-124, and
generated additional maps for the 20 most abundant miRNAs present in P13

mouse brain. We also found that the relatively large number of Ago proteins
bind in coding sequence, as well as introns, suggesting unexplored functions for
miRNAs. Not all Ago mRNA clusters correspond to known seed sequence,
leading to the discovery of putative new rules for miRNA-mRNA interactions.
HITS-CLIP provides a general plaform to identify functional mRNP and miRNA
binding sites in vivo and a solution to determining precise sequences for
targeting clinically relevant sites of RNA regulation. In addition, overlaying
mRNP maps with miRNA maps will be informative for the understanding of
RNA regulations and complexity.
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CHAPTER I. GENERAL INTRODUCTION

RNA complexity
Each cell in our bodies contains a set of genes, from which information flows to
precisely controlled genetic transcripts called messenger RNAs (mRNAs) that
encode distinct functional outputs as translated proteins. The central dogma of
molecular biology suggests that more complex organisms with more diverse
function could be associated with larger numbers of genes (Mattick, 2003).
However, genome sequencing projects reveal that the number of protein‐coding
genes in human (~22,808) is similar with lower organisms such as mouse
(~22,010) (Waterston et al., 2002) and C. elegans (~19,427) (Consortium, 1998).
This discrepancy between organismal complexity and number of genes could be
explained by sophisticated regulatory mechanisms acting on RNA, where
increased diversity leads to the amplification of genomic complexity (Sharp,
2009). As the coding capacity in DNA is increased by the different usage of
promoters controlled by various DNA‐binding proteins (Davuluri et al., 2008),
the same extent of increase in RNA complexity is expected from alternative
usage of exons, RNA editing and polyadenylation controlled by RNA‐binding
proteins

(RNABPs).

Furthermore,

post‐transcriptional

regulation

of

the

degradation (Houseley and Tollervey, 2009; Richter, 2008), translation and
1

localization of mRNA (Rodriguez et al., 2008) are also controlled by specific
RNABPs through encoded RNA sequences beyond gene‐coding information,
such as RNA regulatory elements in introns for alternative splicing (Dredge and
Darnell, 2003) or in 3’untraslated regions (3’UTRs) (Keene, 2007). Such regulation
depends on the recognition of RNABPs to cis‐acting RNA elements, which are
more divergently encoded through evolution than the protein sequence of
RNABPs, generating different RNA complexity leading to organismal diversity
(Jelen et al., 2007).

More recently, identification of a small regulatory RNAs‐protein complex, called
RNA‐inducing silencing complex (RISC) underscores the possibility of increased
complexity by microRNAs (miRNAs) (Bartel, 2004), as each miRNA is believed
to bind directly to many mRNAs to regulate their translation or stability
(Filipowicz et al., 2008). Many miRNAs are evolutionarily conserved, although
others are species‐specific (including human miRNAs not conserved in
chimpanzee), consistent with roles ranging from generating cellular to
organismal diversity (Berezikov, 2006). Therefore, complex organisms are
thought to have evolved along with a diversification of RNA output, mediated
by regulatory RNA‐protein and RNA‐RNA interactions (Figure 1.1).

2

RNA regulation for complexity
RNA complexity is contributed by various RNA regulatory events controlled by
RNABPs or non‐coding RNAs including miRNAs (Figure 1.1). The diversity
generated by such RNA regulation is likely to contribute to different functions in
tissues with the same genomic coding capacity. By regulating RNA complexity
through alternative splicing, alternative polyadenylation, RNA editing, nuclear
export, localization, mRNA turnover and translational regulation, RNABPs
(Lunde et al., 2007) and miRNAs (Ambros, 2004; He and Hannon, 2004) control a
wide range of activities, including development, immune function and neuronal
biology, consistent with its critical roles in cellular function and organismal
diversity (Figure 1.1).

The role of RNABPs is especially critical in cellular functions in neurons, highly
specialized cells with impressive complexity (Ule and Darnell, 2006). Neuronal
RNABPs such as neuro‐oncological ventral antigen (Nova) regulate neuron
specific splicing to generate a versatile repertoire of proteins, functioning in
synapse (Huang et al., 2005). In addition to increasing diversity of gene products,
RNABPs also have special roles in spatial control of mRNAs, required by
complicated structure and function of neurons (Figure 1.1) (Rodriguez et al.,
2008). Neurons have small cell bodies relative to their extended projections,

3

which form complicated neuronal circuitry and require rapid response to the
communication signal in synapse. To overcome such a long distance from
nucleus to neuronal processes, RNABPs such as fragile‐X mental retardation
protein (FMRP) (Antar et al., 2004; Antar et al., 2005; De Diego Otero et al., 2002)
and Zip code binding protein 1 (ZBP1) (Bassell et al., 1998; Zhang et al., 2001a)
can deliver mRNAs from nucleus to neuronal processes, and may act by
localizing with and suppressing the translation of target mRNAs to induce local
protein translation in the presence of communication signals such as
neurotransmitters. In addition to RNABPs, miRNAs such as miR‐134 is also
known to localize in dendrites to regulate synaptic plasticity through local
translation (Schratt et al., 2006; Siegel et al., 2009). Therefore, it is perhaps not
surprising that perturbations of RNA regulators are associated with variety of
neurological diseases. Here a few examples of such RNA regulators are
introduced to elucidate their diverse roles in RNA complexity and function.

‐Alternative Splicing (Nova)
Nova is a target antigen in a paraneoplastic neurologic disorders (PND) termed
paraneoplastic

opsoclonus

myoclonus

ataxia

(POMA),

an

autoimmune

neurologic disease characterized by abnormal motor inhibition (Luque et al.,
1991). Western blot analysis with POMA antisera detects three antigens, Nova‐1,
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Nova‐2 and Supernova. Nova‐1 is a 50‐55 kD antigen expressed in the ventral
midbrain, hindbrain, and ventral spinal cord (Buckanovich et al., 1993). Nova‐2 is
a 50 kD antigen expressed in neocortex, thalamus, inferior colliculus, and the
external granule cell nuclei of the cerebellum (Yang et al., 1998). Supernova is an
antigen of 70‐75 kD, which may come from alternative start codon usage of
Nova‐2 gene. Nova‐1 null mice die at 7‐10 days after birth with a profound motor
failure (Jensen et al., 2000a). Nova‐2 null mice show similar post‐natal lethal
phenotype as Nova‐1 null mice (Ruggiu M., personal communication).

Nova proteins contain three functional hnRNP K‐homology type (KH‐type)
RNA‐binding domains and function as brain specific splicing factors which
regulate the splicing of target RNAs (Buckanovich and Darnell, 1997). A specific
sequence element, YCAY tetramer (where Y indicates a pyrimidine, U or C ) was
identified as a Nova RNA ligand by in vitro RNA selection (Jensen et al., 2000b),
X‐ray crystallography (Lewis et al., 2000) and further confirmed by in vivo cross‐
linking and immunoprecipitation (CLIP) (Ule et al., 2003), a method developed
to screen in vivo protein‐RNA interaction in the Darnell lab. In addition, custom
splicing microarray from Affymetrix revealed that Nova regulates the splicing of
target RNAs encoding proteins that function mostly at the synape (Huang et al.,
2005). Based on splicing changes and location of YCAY motifs in ~50 validated
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targets, it was possible to generalize the rule of Nova’s action and more targets
were identified by the prediction depending on the position of YCAY clusters
(Ule et al., 2006). In detail, recruitment of Nova on exonic YCAY clusters changes
the protein complexes assembled on pre‐mRNA, blocking U1 snRNP binding,
and inhibiting exon inclusion. However, binding of Nova on intronic YCAY
clusters enhances spliceosome assembly and subsequently induces exon
inclusion by means of removal of introns closest or harboring YCAY clusters (Ule
et al., 2006). So far, 84 Nova targets have been identified by experimentally
validating that their alternative splicing is dependent on Nova. In addition, long‐
term potentiation (LTP) of the slow inhibitory postsynaptic current (sIPC) was
abolished in Nova‐2 null mice (Huang et al., 2005) and clustering of acetylcholine
receptors (AChRs) at the neuromuscular junction (NMJ) is failed in Nova‐1/Nova‐
2 double knockout (DKO) mice but rescued in the DKO mice breeding with a
Nova dependant isoform of agrin, containing inserts at a splice site called “Z”
(Z(+) agrin) (Ruggiu et al., 2009). Such observations showing that RNA
complexity, generated from the RNABP dependant splicing events, is important
in neuronal function.

6

‐Translational control (FMRP)
Fragile X syndrome is the most common inherited form of mental retardation
disease, which is generally caused by the absence of the RNA binding protein
called fragile X mental retardation protein (FMRP). This typically occurs because
of expansion of a CGG repeat in the upstream region of corresponding gene,
FMR1, leading to transcriptional silencing (Jin and Warren, 2000). Several RNA
binding domains and corresponding ligands are identified in FMRP (Kaytor and
Orr, 2001). Using in vitro RNA selection, it has been found that the RGG box, a
RNA binding domain enriched in arginine and guanine residue, could interact
with the specific RNA structure called a G‐quartet, a planar conformation with
four guanine residues (Darnell et al., 2001). In addition, the KH2 domain, the
second RNA binding domain in tandem KH‐type domain of FMRP, could
recognize an RNA structure called a loop‐loop pseudoknot or kissing complex
(Darnell et al., 2005). Of note, a missense mutation (I304N) in the KH2 domain is
associated with severe disease in a patient, and the KH2 RNA ligands compete
FMRP off of brain polyribosomes, suggesting that kissing complexes may be
FMRP target ligands for translational regulation (Darnell et al., 2005; Feng et al.,
1997; Stefani et al., 2004). It has been thought that FMRP could bind its target
mRNAs and regulate their local translation depending on the neuronal activity
(Garber et al., 2006). So far, several candidate FMRP targets have been identified
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from various approaches but few targets are well validated due to lack of a clear
functional assay, as well as difficulties in detecting subtle change at the protein
level of the targets and issues of potentail functional redundancy with the Fragile
X related proteins FXR1P and FXR2P. One of the best validated target mRNAs is
microtubule associated protein 1B (MAP1B), of which expression is slightly
elevated in FMR1 null mice (Lu et al., 2004). In addition, the MAP1B fly homolog
Futsch, is elevated in Drosophila Fmr1 null flies (Zhang et al., 2001b). This finding
may partly explain the delayed dendritic spine maturation phenotype in fragile X
mental retardation patients as well as in Fmr1 knockout mice (Irwin et al., 2000;
Nimchinsky et al., 2001). Taken together, it is believed that most FMRP targets
are anticipated to have functions in synaptic development related with learning
and memory. The Fragile X syndrome illustrates the critical role of RNABPs in
neuronal function and pathogenesis of the disease, emphasizing the importance
of RNA complexity generated from their different set of targets and locations
where translation is under control.

‐miRNA mediated post‐transcriptional control
miRNAs are small non‐coding RNAs which repress gene expression through
post‐transcriptional control. They are approximately ~22 nucleotides in length
and hybridize to the 3’UTR of target mRNAs through partial base pairing (He
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and Hannon, 2004). The first miRNA, lin‐4, was discovered by screening of
genetic mutants showing developmental defects in Caenorhabditis elegans and is
known to have antisense complementarity to the 3ʹ untranslated region of lin‐14
(Lee et al., 1993). As target mRNAs usually remain intact after partial base
pairing to miRNAs, it is believed that most miRNAs induce translational
repression through incomplete hybridization, while in a subset of cases of perfect
base pairing induces degradation of target mRNAs (Bartel, 2004).

The mechanism for miRNA‐mediated translational repression is largely
unknown. Each miRNA is believed to bind directly to many mRNAs to regulate
their translation or stability and thereby control a wide range of activities,
including development, immune function and neuronal biology (Ambros, 2004).
Therefore, RNA regulation by miRNAs could generate great complexity at the
post‐transcriptional level, which may explain the gap between the great
complexity of cellular functions and the limited number of primary transcripts.
Furthermore, some miRNAs are species‐specific, including ~50 miRNAs present
in human that are not conserved in chimpanzee, although many miRNAs are
evolutionarily conserved (Berezikov, 2006). Like neuronal RNABPs localized in
dendrite for local translation control in neuron, neuronal miRNAs such as miR‐
134 are also reported to localize in dendrite to regulate activity dependent local
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translation of target mRNA, generating another RNA complexity in terms of
different space and location under control (Schratt et al., 2006; Siegel et al., 2009).

Systematic approaches for RNA regulation study
Completion of human genome projects (Lander et al., 2001) and recent
technological advances in biological experiments such as microarray (Schena et
al.,

1995),

high‐throughput

sequencing

(Hutchison,

2007),

cross‐linking

immnoprecipitation (CLIP) (Ule et al., 2003) and bioinformatics enable
investigators to study systematic views of RNA regulation. Accordingly,
genome‐wide RNA maps can be generated based on the characteristics of RNA
populations measured by these new methods depending on cellular context,
giving genome‐wide insights into new biological functions of RNA regulation
(Ule et al., 2006). Here several examples of such methods are introduced to show
the current states of technologies for studying genome‐wide RNA regulations.

‐Microarray
Systematic efforts to characterize RNA population began with microarrays,
technologies developed to measure abundance of mRNAs with initial interest in
mRNA level changes induced by transcriptional regulations (Schena et al., 1995).
Microarrays have been widely used to characterize gene expression patterns in
10

many cells and tissues under diverse conditions, giving us systematic pictures of
the transcriptional responses of the human genome to variety of physiological
and pathological conditions (Brown and Botstein, 1999). Moreover, microarray
technologies have also recently been applied to studying a post‐transcriptional
control of mRNAs, an important regulatory mechanism in gene expression with
richer regulation than transcriptional control. For this, microarray has been
modified into a variety of different platforms to elucidate such an RNA
complexity, particularly of splice variants using probesets for alternative exons
identified from previous experiments or genome sequencing data (Modrek and
Lee, 2002).

Exon junction microarray is designed to have specific probesets for the sequences
in exon junctions, including the junctions generated by alternative splicing
events. RNA populations from different tissues were examined by the exon
junction microarrays, leading to initial estimation that a large number of human
genes (~3/4) are alternatively spliced (Johnson et al., 2003). Tissue‐restricted
patterns of alternative mRNA expression are somewhat explained by the
evidence that they could be modulated by tissue specific RNABP (Ule and
Darnell, 2006). Although exon junction microarray is specific and sensitive
enough for detecting alternative mRNA isoforms, it is limited by the current state
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of gene annotations, and unable to identify the novel splicing isoforms. In an
effort to overcome this, exon microarrays, which interrogate complete sets of
transcribed exons, were developed to measure the usage of individual exons not
only detecting for novel alternative mRNA splicing isoforms but also for
different polyadenylation (Bemmo et al., 2008; Clark et al., 2007). Furthermore,
exon arrays also provide a more reliable way for estimating mRNA abundance
using multiple probesets for each exon. Recently microarray platforms are
further expanded to cover all genome sequences, called “tiling array”, enable to
detect and study all transcriptiome (Johnson et al., 2005). Although microarray
technologies use sophisticated algorithms for designing probe sequences and
also for data analysis, it is still has a limitation that experiments are dependent
on nucleic acid hybridization which could be biased accordingly to sequence
composition.

‐High‐throughput sequencing
Recent technology advances in sequencing enable to read billions of nucleotides
in sequences in low‐cost, opening the new age of sequencing that enable to begin
personal genome analysis. The high‐throughput sequencing, often called next‐
generation sequencing, was achieved by several platforms which parallelize the
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process with different advanced reading technologies (Hutchison, 2007). Among
them, 454, Solexa/Illumina, and SOLiD sequencing technologies are widely used.

454 sequencing is highly parallel pyrosequencing system, which reads a fiber‐
optic slide of individual wells, where DNA is amplified using an emulsion PCR
method and is extended for sequencing in the solid support by DNA polymerase
pyrophosphates (Margulies et al., 2005). During the extension, it adds one
nucleotide species at a time and quantifying the number of nucleotides added to
a given location by detecting the release of attached. This method can read total
400 million bases, generating up to 400 base pair reads, at 99% or better accuracy
per run. Solexa/Illumina sequencing technology requires planar, optically
transparent surfaces to physically attach DNA molecules in parallel and
amplifies them as bridge but uses reversible terminator methods to read the
sequencing by DNA polymerase (Bennett, 2004; Bennett et al., 2005). During the
process, it adds one nucleotide at a time, detecting fluorescence dye‐termination
at each position and repeating removal of terminator group for another
nucleotide extension, ensuring high accuracy and true base‐by‐base sequencing.
Furthermore, it can be expanded to paired‐end sequencing, which read
sequences from the opposite ends by regenerating the templates after completion
of the first read. This method can read total more than 20 billion bases,
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generating ~75bp reads (~36bp reads for single‐end sequencing). The SOLiD
platform parallelizes the process by performing emulsion PCR with primer‐
coated beads for amplification and eliminating beads without template or with
two different templates for enrichment (Shendure et al., 2005). For reading, it
uses a DNA ligase to preferentially extend to the annealed oligonucleotide, one
from the pool of all possible oligonucleotides of a fixed length, labeled according
to the sequenced position with 2 base encoding. Due to the 2 base encoding, it
provides sequencing accuracy greater than 99.94% and generates over 20
gigabases and 400M tags per run.

Taking advantage of the power of high‐throughput sequencing technologies,
complete RNA profiles are currently able to be produced (Wang et al., 2009).
Such an application called “RNA‐Seq”, which uses high‐throughput sequencing
technologies to sequence complementary DNA (cDNA) in order to get
information about a sampleʹs RNA content, was used to assess mRNA
complexity, providing analysis of alternative splicing and polyadenylation
variants in difference tissues (Pan et al., 2008). The advantage of this method is to
identify uncharacterized mRNA isofoms and novel non‐coding RNAs, which
can’t be achieved by other methods such as microarray (Blencowe et al., 2009).
Furthermore, high‐throughput sequencing can be coupled with other methods,
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which select and enrich the subset of RNA population, to identify and estimates
the abundance of subset with improved signal:noise.

‐Cross‐linking and immunoprecipitation (CLIP)
Regulating the complexity of RNA has been shown to be mediated by variety of
RNA binding protein and non‐coding RNAs. To identify the functional targets
and regulatory mechanism of these regulators, researchers developed variety of
biochemical approaches for screening RNA targets (Darnell, 2006). But a critical
caveat common to all of these approaches is their inability to definitively
distinguish direct from indirect effects. For identifying direct targets through
RNA‐protein interactions, several biochemical methods have been developed
based on immunoprecipitation (IP) of RNABPs followed by purification of
bound RNA and characterization by RT‐PCR or microarray analysis, which are
proven to be useful to identify functional RNA targets in vivo (Keene et al., 2006).
However, these methods are limited by poor specificity due to the low
stringency of such co‐IPs causing pulling down of secondary RNABPs, non‐
specifically bound RNAs, and problems of RNABP‐RNA re‐association in vitro
(Mili and Steitz, 2004). To overcome such drawbacks in signal:noise ratio, a
further improved method of identifying direct RNABP‐RNA interactions in vivo
has been developed, which is named cross‐linking and immunoprecipitation
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(CLIP) assay (Jensen and Darnell, 2008; Ule et al., 2005a; Ule et al., 2003). CLIP
uses ultraviolet (UV) irradiation to covalently crosslink RNA‐protein complexes
that are in direct contact within the range of approximately single Angstrom
distances in living cells, allowing them to be stringently purified. Partial RNA
digestion reduced bound RNA to fragments that can be sequenced, providing a
new opportunity to identify direct RNA‐protein interactions.

‐Bioinformatics
Bioinformatics has emerged as a powerful approach to compliment to current
experimental technologies for analyzing RNA regulations. It enables one to mine
general rules from massive data generated by high‐throughput experiments and
also to generate new hypotheses predicting RNA regulation by sequence analysis
from the data. A fundamental analysis common to all of these bioinformatics
analysis is to identify RNA regulatory elements to understand rules of RNA
regulation. To identify such RNA elements, initially simple pattern‐matching
algorithms with exhaustive tree searches such as RNAmot, RNAbob, RNAmotif
and PatSan algorithms were developed (Dsouza et al., 1997; Laferriere et al.,
1994; Macke et al., 2001). However, they have limitations in sensitivity and also
need an accurate consensus sequence for searching.
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Two main approaches, comparative sequence analysis and energy minimization,
which considers formation of RNA secondary structures, have been applied to
improve the bioinformatics methods for RNA. Comparative sequence analysis
uses phylogenetic information to build stochastic context free grammar models
for RNA, considering base pairs from pairs of aligned sequences covarying in a
Watson‐Crick pair, and dynamic programming for searches (Eddy and Durbin,
1994; Sakakibara et al., 1994). The limitation of this approach is that it requires
many diverse sequences and highly accurate multiple alignments. Energy
minimization approaches have been developed utilizing calculated free energies
of RNA secondary structures predicted by Mfold (Mathews et al., 1999; Zuker
and Stiegler, 1981) or RNAfold (Hofacker, 2003) programs. These algorithms
evaluate all feasible structures for a given RNA sequences, and find the one with
minimal free energy based on dynamic programming. They are also able to
calculate explicit partitional functions, the sum of exponentiated energies over all
possible folds for analyzing probabilities of each base pairing (McCaskill, 1990),
which can be utilized to identify structural RNA elements. One drawback of this
approach is that it gives many different structures within the error range of the
global optimum with minimal free energy. Integrated methods have been under
developement for better performance and are expected to be applied to identify
new functional RNA elements more precisely.
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As the number and depth of available sequences and data from genome
databases and high‐throughput experiments are increasing, so too bioinformatics
analysis need increasingly to be applied to RNA studies. Such analyses have led
to great success in understanding RNA regulation. Sequence‐based approaches
considering sequence conservation across species have been used for studying
pre‐mRNA processing and identified regulatory elements for 5’ splicing sites
(Lerner et al., 1980), consensus elements for alternative splicing (Castle et al.,
2008) and the poly adenylation signal for 3’ end processing of transcripts
(Beaudoing et al., 2000). Bioinformatics approaches are also important in
identifying putative miRNAs, primarily for sequence conservation and RNA
secondary structure to screen conserved sequences forming hairpin loop
structures of pre‐miRNAs (Bentwich et al., 2005). In addition, similar approaches
are also critical in attempting to identify potential microRNA binding sites in 3’
UTRs (Rajewsky, 2006).

MicroRNAs and target regulations.
MicroRNAs (miRNA) are single stranded non‐coding RNA molecules of
approximately 21~23 nts (Lagos‐Quintana et al., 2001). Functional miRNAs are
generated from short stem‐loop structures called pre‐miRNA which is also
processed from primary transcript called pri‐miRNAs (He and Hannon, 2004;
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Kim et al., 2009b). Mature miRNAs are partially complementary to targets and
play an important role in down‐regulate gene expression through controlling
mRNA translation or degradation. Depending on the function of targets,
miRNAs control a variety of cellular functions including development, immune
function and neuronal biology. Dysregulation of miRNAs are reported to be
associated with many diseases, such as cancer and neurodegenerative disease
(Hammond, 2006; Kim et al., 2007). Therefore, idetification of targets is important
to understand the function of each miRNA in cellular function and pathogenesis

‐Generation of miRNAs
The genes producing miRNAs are much longer than the mature miRNAs and
often contain multiple miRNAs as clusters. They may be encoded in independent
genes or the parts of other genes such as introns and 3’UTRs (Murchison and
Hannon, 2004). First, they are transcribed as primary transcripts called pri‐
miRNAs by RNA polymerase II or III (Borchert et al., 2006; Lee et al., 2004). Then,
pri‐miRNAs are processed into ~70 nucleoide stem‐loop structures called pre‐
miRNAs, performed by microprocessor complex (Denli et al., 2004), consisting of
RNase III enzyme Drosha (Lee et al., 2003) and Pasha/DGCR8 (Denli et al., 2004;
Han et al., 2004). Processed pre‐miRNAs are exported out of the nucleus via
Exportin 5 in a Ran‐GTP dependent manner (Bohnsack et al., 2004; Lund et al.,
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2004; Yi et al., 2003). In the cytoplasm, pre‐miRNAs are further processed to
mature miRNAs by an RNase III enzyme called Dicer (Bernstein et al., 2001).
Dicer cleaves a pre‐miRNA stem‐loop or a dsRNA, producing ~20‐25 base pair
RNA fragments with a 2 nucleotide 3’ overhang (Zamore et al., 2000). Only one
strand of two complementary short RNA fragments is selected to initiate the
formation of the RNA‐induced silencing complex (RISC). It is called the guide
strand and is selected by the Argonaute (Ago) protein, a critical core component
in RISC to repress translation of target mRNA (Gregory et al., 2005). Ago in the
RISC complex forms an Ago‐miRNA‐mRNA ternary complex and shows RNase
activity depending on the complementary between miRNA and target mRNA
(Bartel, 2009). The remaining strand, called passenger strand, is cleaved quickly
and is subsequently degraded by RISC as substrate (Matranga et al., 2005). The
remaining mature miRNA recognizes complementary binding sites located in
3’UTRs of target mRNAs and functions as a guide for effectors, such as
Argonaute proteins, to regulate mRNA stability or repress translation (Pillai et al.,
2007).

‐miRNAs and Argonaute proteins
Argonaute proteins (Ago, also called Eif2c) are the catalytic components of RISC,
which responsible for the gene silencing called RNA interference (RNAi). Ago
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binds small interfering RNA (siRNA) fragments and cleaves messenger RNA
strands that are perfectly complementary to their bound siRNA (Carmell et al.,
2002). But endogenously expressed miRNA, which are also bound by Ago, are
usually partially complementary to target mRNA and regulate target gene
expression via translational repression. Human has 4 Ago proteins (Ago1‐4),
which are ubiquitously expressed in many organisms (Hutvagner and Simard,
2008). Ago proteins are ~100kD proteins that contain three domains, namely PAZ,
Mid and PIWI domains. The PAZ domain has been identified in Ago and Dicer,
binding to single stranded RNAs (ssRNAs) recognizing the 3’‐end of ssRNAs
(Lingel et al., 2003). PAZ serves as a 3ʹ‐end binding module for siRNA transfer in
the RNA silencing pathway, and as an anchoring site for the 3ʹ‐end of guide
RNA within silencing effector complexes (Ma et al., 2004). The C‐terminal PIWI
domain, which is highly conserved, is known to have similar folding with
RNaseH, suggesting that Ago proteins are the silencer in RISC complex with
nuclease activity (Song et al., 2004). Among the four human AGO proteins, only
AGO2 showed silencer activity and mutation in its PIWI domain abolished RISC
activity (Liu et al., 2004; Meister et al., 2004). Ago ternary complexes, Ago‐
miRNA‐mRNA, can accumulate in cytoplasmic foci, known as processing‐bodies
(P‐bodies, cytoplasmic bodies or GW bodies), which are regions with high rates
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of mRNA decay and translational repression (Jackson and Standart, 2007; Liu et
al., 2005; Sen and Blau, 2005).

Recent X‐Ray crystal structures of a ternary complex of Ago bound to both a 21‐
mer DNA guide strand (miRNA equivalent) and a 12 nt fragment of
complementary RNA (target mRNA quivalent) suggest that these three
molecules make close contacts (Wang et al., 2008a). The seed region (position 2 to
8) of the guide strand forms paired duplex with target RNA and both ends of the
strand anchored in the Ago protein. In detail, the PAZ domain interacts with two
terminal bases on the 3’end of guide DNA and a pocket between the middle
domain (Mid) and the PIWI domain binds to the 5’‐phosphate of the strand,
widens on formation of ternary complex. Interestingly, guide‐strand bases 11‐18
are disordered in the crystal structure with target RNA in duplex, suggesting a
high degree of mobility in this part.

‐miRNA target predictions and identification.
The initial observation of a lin‐4 miRNA target, lin‐14 mRNA, showed some
clues about the miRNA target sites. miRNA target sites are conserved sites in
3’UTR with partial complementarity to the corresponding miRNA sequence (Lee
et al., 1993). Despite the increasing clues about miRNA target recognitions and
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the need for target identification, it has not been easy to make a general
determination about the specific RNA targets upon which they act. The problem
stems from the observations that in animals most of miRNA target sites have
partial complementarity. Due to the limited complementarity of target sequences,
initial bioinformatics target‐predictions produced great divergent results
although they constrained predictions for evolutionarily conserved sequences in
the 3’UTR and considered free energy of the entire miRNA‐mRNA duplex (John
et al., 2004; Kiriakidou et al., 2004; Lewis et al., 2003). The most significant
contribution to target recognition is perfect Watson‐Crick base pairing of miRNA
seed region (position 2‐7), and this information has been used to improve target
predictions such as TargetScan (Lewis et al., 2005). The wide spread of miRNA
seed matches in 3’UTR was also observed from the bioinformatics analysis with
sequence conservarion, supporting the importance of miRNA seed region for its
target recognition (Xie et al., 2005).

Most bioinformatics predictions of miRNA binding sites are based on miRNA
seed sequences and conservation but also consider slightly different additional
features to improve their performances. The PicTar algorithm uses a
combinatorial approach, based on the assumption that differently co‐expressed
miRNAs coordinately regulate target (Krek et al., 2005). The PITA algorithm
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considers target site accessibility, based on the assumption that free energy
gained from the formation of miRNA‐target hybridization should compensate
the energy needed to unfold target RNA (Kertesz et al., 2007). A critical caveat
common to all of these conservation based approaches is their inability to
definitively identify species specific (non‐conserved) miRNA target sites or target
sites located in the regions other than the 3’UTR. In fact, sites outside of the 3’
UTR can act as functional sites for miRNA regulation (Rosa et al., 2009; Tay et al.,
2008). To overcome such limitations, RNA22, a pattern‐based method which does
not rely on conservation, was developed (Miranda et al., 2006). But it still has
inherited the restriction that the initial pattern learning was trained from
conserved sequences. Such bioinformatic efforts have greatly improved the
ability to recognize bona fide miRNA binding sites. However, slightly different
algorithms applied to the same sets of sequences still produce poor overlapping
results among the predictions, which is a concern in terms of false positives and
negatives (Rajewsky, 2006).

Experimental approaches combined with bioinformatics analysis also attempted
to identify miRNA targets. After miRNAs were introduced into HeLa cells,
microarray analysis revealed evidence for targets, showing decreased transcripts
level depending on miRNA expression and enriched seed matches to
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corresponding miRNAs (Lim et al., 2005). Furthermore, miRNA overexpression
or knockdown studies, most recently in combination with proteomic studies,
have led to the conclusion that individual miRNAs generally regulate a relatively
small number of proteins (~40) at modest levels (< 2‐fold) (Baek et al., 2008;
Selbach et al., 2008). A limitation of such studies is their inability to definitively
distinguish direct from indirect miRNA‐target interactions. Biochemical methods
were developed to identify the direct targets by identifying mRNAs
coimmunoprecipitating

with

silencing

complexes

using

microarray

or

sequencing (Beitzinger et al., 2007; Easow et al., 2007; Hammell, 2008;
Hendrickson et al., 2008; Zhang, 2007). However those methods are not able to
definitively

define

miRNA

targets

sites

and

raise

the

concern

that

immunoprecipitation of RNA‐protein complexes may be susceptible to
rearrangements and poor signal:noise ratios, requiring cross‐linking strategies
like CLIP (Ule et al., 2003) to get high resolution of binding sites and reduce the
noise from the background. Furthermore methods based on CLIP may be able to
provide new rules of miRNA target recognition beyond seed pairing.

‐Mechanism of miRNA mediated post‐transcriptional repression.
The mechanism of miRNA mediated post‐transcriptional repression is still
largely unknown. It has been believed that most miRNAs induce translational
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repression rather than the degradation of target mRNAs, with exception of few
targets harboring the perfect match sites to miRNA sequence (Yekta et al., 2004).
Translational repression of lin‐14 mRNA by lin‐4 miRNA does not alter lin‐14
mRNA association with polyribosomes (Olsen and Ambros, 1999), initially
suggested that miRNA repression could happen after the translation initiation
step. This hypothesis was further supported by the same observations with other
target mRNAs (Maroney et al., 2006; Nottrott et al., 2006; Petersen et al., 2006).
However, this hypothesis was then challenged by a report that target mRNAs are
shifted to the top of polyribosome when their expression is repressed by
miRNAs (Pillai et al., 2005). It was also observed that miRNAs can not repress
M7G‐cap‐independent translation via internal ribosome entry site (IRES), or
recruit some translation initiation factors through RISC, suggesting that miRNAs
interfere with mRNA translation at the initiation step (Chendrimada et al., 2007;
Humphreys et al., 2005; Mathonnet et al., 2007; Pillai et al., 2005). In some cases
miRNAs have been observed to mediate deadenylation and decay of targeted
mRNAs together with its translational repression (Behm‐Ansmant et al., 2006;
Giraldez et al., 2006; Wakiyama et al., 2007; Wu et al., 2006). Regardless of the
mechanism, it has been noted that reduced protein levels are frequently
associated with decreased mRNA levels following miRNA suppression (Selbach
et al., 2008) (Baek et al., 2008).
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Other regulatory factors associated with RISC or target mRNA might explain the
differences in such mechanisms. While incompletely understood, there is some
evidence that RNABPs play role in miRNA dependant translational regulation.
HuR, an AU‐rich‐element binding protein, binds to 3’UTR of the CAT1 mRNA
after stress and the binding inhibits the CAT1 repression by miR‐122
(Bhattacharyya et al., 2006b). A similar result was reported in a conserved
RNABP, Dead end 1 (DnD1), which also protects mRNAs from miRNA‐
mediated repression through interacting with the same miRNA target (Kedde et
al., 2007b). RNABPs may not only inhibit but also enhance miRNA mediated
repression. It is reported that binding of HuR to 3’UTR of c‐Myc recruits let‐7‐
loaded RISC and represses c‐Myc expression (Kim et al., 2009a). Furthermore,
RNABPs may be involved in switching of miRNA mediated repression to
activation. Upon cell cycle arrest, an AU‐rich element (ARE) recruits miR‐369‐3
associated RISC together with the fragile X mental retardation‐related protein 1
(FXR1) RNA binding protein to tumor necrosis factor‐alpha (TNFalpha) mRNA
and activates translation (Vasudevan et al., 2007). Taken together, these data
suggest that effects of miRNA‐mediated regulation on targets can be different
depending on the context of RNABP associated with the target mRNA. However,
a major limitation is lack of understanding of location of binding sites of both
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RNABPs and miRNAs on target transcripts, which is pre‐requisite to
understanding mechanisms.

‐Biological functions of microRNAs and targets
Since the first discovery of miRNA, lin‐4, which was identified due to its critical
roles in the timing of C. elegans larval development, more discoveries of
miRNAs from genetic screening have implicated miRNAs in the regulation of
biological processs and function (Johnston and Hobert, 2003; Lee et al., 1993).
Several knockout mice of components in the miRNA processing pathway were
generated. Dicer1‐null mice are lethal in early development and their embryonic
stem (ES) cells were not able to be generated, showing the importance of miRNA
in maintaining stem cell populations during early mouse development (Bernstein
et al., 2003). Conditional knockout of Dicer in Purkinje cells, neurons found in the
layered structures of the mammalian cerebellum, was examined in mice and lead
to cerebellar degeneration and development of ataxia by inducing Purkinje cell
death, implicating the involvement of miRNAs in neurodegenerative disorders
(Schaefer et al., 2007). Ago2‐null mice are embryonic lethal and unable to
response to siRNAs, indicating the critical role for miRNAs in mouse
development and Ago2 in siRNA response (Liu et al., 2004). Loss‐of‐function
studies of specific miRNAs in mice have also been used to elucidate their
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functions and targets. miR‐1‐2 null mice showed heart defects with enrichment
of seed matches to miR‐1 in upregulated transcripts, elucidating the role of miR‐
1‐2 in cardiogenesis (Zhao et al., 2007). By generating miR‐150 null mice, it was
found that miR‐150 plays role in lymphocyte maturation through regulating its
target, cMyb (Xiao et al., 2007).

It has also been reported that dysregulation of miRNAs are associated with
human disease. miRNA profiles in cancer tissues are surprisingly informative,
differentiating type and state of tumors more accurately than mRNA expression
profiles (Lu, 2005). miRNAs in the miR‐17‐92 cluster are often amplified in
human B‐cell lymphomas and their expression is reported to accelerate tumour
together with c‐Myc as oncogene (He et al., 2005). The miR‐34 family is known to
be activated by p53 and to induce cell cycle arrest through target regulation,
implying its role as tumor repressor together with p53 (He et al., 2007). Restoring
the expression of miR‐126 suppresses tumor and miR‐335 inhibits metastasis
through regulating its target, SOX4 (Tavazoie et al., 2008). Such reports showing
tumor suppressor activity of miRNAs suggest potential therapeutic use in cancer.
Interestingly, introducing of miR‐26a using adeno‐associated virus (AAV) into
mouse model of hepatocellular carcinoma protects from disease progression,
presumably through regulation of its targets, cyclins D2 and E2 (Kota et al., 2009).
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Diseases other than cancer are also associated with miRNAs. miR‐133b is
reported to be absent in midbrain tissue of Parkinson’s disease patient and have
role in dopaminergic neuronal function through regulating its target, Pitx3 (Kim
et al., 2007). Interestingly, mutation in the seed region of miR‐96 is associated
with progressive hearing loss in both human disease and mouse mutants,
implicating the importance of seed region in target recognition and regulation of
biological function (Lewis et al., 2009; Mencia et al., 2009)

Aim of the thesis
The overall goal of this study is to systematically define the functions of RNA
regulation as it relates to RNA complexity. For this purpose, we have tried to
develope a new genome‐wide method for RNA regulation study called HITS‐
CLIP (High‐throughput sequencing and cross‐linking immunoprecipitation). We
have applied this method to the study of two major RNA regulators, the RNA
binding protein (Nova) and the Ago‐miRNA RISC complex. Focusing on RNA
regulation by miRNAs, a specific hypothesis regarding the regulatory function
and mechanisms was generated and examined by combined computational‐
experimental approaches. Such studies provide a means to explore genome‐
wide RNA regulation, expand our understanding of RNA complexity and
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provide advanced understanding of miRNA target regulations in vivo, which are
critical for functional studies and also become increasingly important for RNA
interference based therapeutics.
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Figure 1.1. RNA complexity regulated by RNABPs and miRNAs.

A. RNA regulation by RNABPs in neuron.

In the nucleus, RNABPs (red

asterisks) regulate alternative splicing, alternative polyadenylation and mRNA
export. through their direct interaction with primary mRNAs. In the cytoplasm,
they also regulate mRNA stability, mRNA localization and local translation
which occur in dendrites mostly through their interaction with 3’UTR of target
mRNAs. Indeed, local translation is integral to aspects of synaptogenesis, and
activity dependant neuronal function. B. Processing of miRNAs and their RNA
regulations in neuron. In the nucleus, pri‐miRNAs, which produced as long
transcripts, are processed by Drosha (green) and DGCR8 (blue) complex (also
called microprocessor) into pre‐miRNAs, which are the hairpin‐loop structured
precursors of mature miRNAs..Then, pre‐miRNAs are further processed by Dicer
(orange) into mature miRNAs. In the cytoplasm, miRNAs are finally loaded on
the RISC (sky blue) and recognized the target mRNAs to induce post‐
transcriptional gene silencing. There is a miRNA (miR‐134) also known to
localize to dendrite to regulate local translation in activity dependant manner
like RNABPs.
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Figure 1.1
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CHAPTER II. EXPERIMENTAL PROCEDURES

Total tissue extract
Tissues were each Dounce homogenized in RIPA lysis buffer (0.5% NP‐40, 0.5%
deoxycholic acid, 0.1% SDS in PBS, 50% glycerol, and Complete protease
inhibitor cocktail (Roche)) sonicated, and centrifuged at 20,000xg at 4oC for 15min.
Protein concentration was determined by Bradford assay. 50ug of protein from
each sample was boiled in SDS‐sample loading buffer and continued for Western
analysis.

RNA preparation
RNA from mouse tissues was extracted using Trizol LS Reagent (Invitrogen).
49:1 chloroform:isoamyl alcohol was added to facilitate aqueous and phenol‐
chloroform organic phase separation. After 15min 12,000xg centrifugation, the
aqueous phase where RNA remained was collected and precipitated with
ethanol at ‐20oC overnight. After precipitation, RNA was pelleted at 20,000xg for
20min at 4oC, washed with 75% ethanol, and then was dissolved in H2O.
Extracted RNA was then RQ1 DNase (Promega) treated at 37oC for 1hr and
underwent a second round of phenol‐chloroform extraction and ethanol
precipitation.
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Immunoblot Analysis
Samples were run on SDS polyacrylamide gels and transferred onto PVDF
membranes (Millipore). Membranes were blocked for 1hr at room temperature in
10% non‐fat milk in Western blot wash buffer (WBWB) (23mM Tris, pH 8.0,
190mM NaCl, 0.1% w/v BSA, 1mM EDTA, 0.5% Triton X‐100, 0.02% SDS).
Respective primary antibodies and horseradish peroxidase‐labelled secondary
antibodies (Jackson Immunoresearch) in 10% milk‐WBWB were used during
incubation from 1hr at room temperature to overnight at 4oC. Blots were washed
with WBWB 5min for 5 times after incubation with each antibody. Signals were
detected by Chemiluminescence (Perkin Elmer) and quantified with Versadoc
Imaging System (Bio‐Rad).

RT‐PCR and qRT‐PCR
cDNA was generated by using random hexamers and Superscript III (Invitrogen).
Once the number of PCR cycle was tested for the linear range, 32P‐dCTP was
added into the PCR reactions for the last two cycles and then run onto
denaturing gels (6% polyarylamide/7M urea). It was exposed to X‐ray film
(Kodak). Quantitative RT‐PCR (qRT‐PCR) was performed by using a MyiQ
single‐color real time PCR detection system, using mouse tubulin as an internal
control, and relative mRNA level (WT vs. DKO) was calculated by ΔΔCt values.
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qRT‐PCR was performed using Taqman (Applied Biosystems) following the
manufacturerʹs protocol

Cell culture
All cell lines were maintained at 37ºC/5% CO2 in DMEM (Mediatech), 10% fetal
bovine serum (Gemini) and pen‐strep (50U/ml; Invitrogen).

Luciferase reporter assays
Dual‐luciferase assays (Promega) were performed 24 h after transfection
according to the manufacturerʹs protocol. Psi‐check2 (Promega) was used for
luciferase reporter and was cotransfected with a miR‐124 and control miRNA
from meridian miRNA Mimic (Dharmacon).Transfections were harvested 48 h
after transfection, and the two luciferase activities consecutively assayed.

CLIP (in vivo Cross‐link and Immunoprecipitation)
Ago HITS‐CLIP was performed as described using a monoclonal Ago antibody,
2A8, generously supplied by Z. Mourelatos (Nelson et al., 2007). Experiments
using the 7G1‐1* antibody were undertaken after recognizing that this
monoclonal

antibody,

obtained

from

batches

generated

by

the

Iowa

Developmental Hybridoma (IDH) bank (Cat # 7G1‐1), were a mixture of clones of

36

anti‐FMRP antibody and anti‐Ago antibody. Ago CLIP with the 7G1‐1* antibody
done in WT P13 mouse brain was in the presence of 200ug of blocking peptide
(KHLDTKENTHFSQPN; mapped to FMRP amino acid 354 to 368), which has
been demonstrated to block FMRP immunoprecipitation by 7G1‐1 (Brown et al.,
2001). 7G1‐1 and 7G1‐1* were obtained from the Developmental Studies
Hybridoma Bank, developed under the auspices of the NICHD and maintained
by the University of Iowa, Department of Biological Sciences, Iowa City, IA
52242. For immunoblot analysis, the anti‐Ago 7G1‐1* antibody was used to detect
Ago proteins; results were confirmed independently with an independent anti‐
Ago antibody (Upstate:04‐085). Other antibodies used (Figure 3.1) were
generously supplied by others; anti‐Ago1 and anti‐Ago2 antibodies were from T.
Tuschl, anti‐FMRP (2F5) antibody was from J. Fallon. Nova HITS‐CLIP was
performed on mouse Nova2 WT and KO (CD1) brains as described (Ule et al.,
2003). After PCR amplification, high throughput sequencing was performed (454
Life Sciences).

UV crosslinking of mouse brains
Cortex from P13 mice were harvested and sat in cold HBSS (50ml 10X Hank’s
balanced salt solution, Ca‐Mg‐free, (Invitrogen), 5ml 1M Hepes, pH 7.4, 445ml
ddH2O) until harvest was complete. Tissues were triturated with a 5ml pipette
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and resuspended in 10 volumes of HBSS. Suspension was irradiated using 10ml
per 10cm tissue culture plate six times for 400mJ/cm2 in Stratalinker (Strategene
model 2400). After irradiation, tissue suspension was collected and pelleted at
2500rpm 10min at 4oC. Pellets were resuspended in HBSS (~2X pellet volume),
distributed to Eppendorf tubes (1 brain per tube), quick pelleted at 4oC. Pellets
(~0.6ml/tube) were kept frozen at ‐80oC until needed.

Immunoprecipitation
For each tube of crosslinked lysate 400ul protein A dynabeads (Dynal) were used.
Beads were washed 3x with 0.1M Na‐phosphate pH 8.0 and then were
resuspended in 400ul of same wash buffer with 50ul of rabbit anti‐mouse Fcγ
bridging antibody, 2.4mg/ml (Jackson Immunoresearch), rotating at room
temperature for 45min. After binding bridging antibody, beads were again
washed 3x with 0.1M Na‐phosphate pH 8.0 and then resuspended in the same
buffer with 8ul of FMRP “specific” 7G1‐1 antibody or 2ul of 2A8 , 5mg/ml
rotating at 4oC over night. Antibody bound beads were washed 3x with 1XPXL
(0.1% SDS, 0.5% deoxycholate, 0.5% NP‐40, PBS tissue culture grade, Ca‐Mg‐free).
Each tube of crosslinked brain bits was lysed with 700ul of 1XPXL with 1X
Complete EDTA‐free protease inhibitor cocktail (Roche) and let sit on ice for
10min. 15ul RNAsin (Promega) and 20ul of RQ1 DNase (Promega) were added
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to each tube and incubated in Thermomixer R (Eppendorf) at 37oC for 5min,
1000rpm. 10ul of 1:10,000 dilution of RNase A, 5mg/ml (USB) was used to
limiting digest RNA at 37oC fro 10min, 1000rpm. Lysates were spun in pre‐
chilled ultra‐microcentrifuge (polycarbonate tubes in TLA 120.2 rotor) at
30,000rpm for 20min at 4oC. Supernatants were carefully removed and added to
prepared tubes of beads for immunoprecipitation for 1.5hrs at 4oC. Beads were
washed with ice‐cold buffer: 2x with 1XPXL, 2x with 5XPXL (0.1% SDS, 0.5%
deoxycholate, 0.5% NP‐40, 5XPBS tissue culture grade, Ca‐Mg‐free) and 2x with
1XPNK (50mM Tris‐Cl pH 7.4, 10mM MgCl2, 0.5% NP‐40).

CIP treatment (on bead)
After

immunoprecipitation,

beads

were

resuspended

in

80ul

of

1X

dephosphorylation buffer and 3ul of calf intestinal alkaline phosphatase (CIP)
(Roche) were added. Beads were incubated in Thermomixer R at 37oC for 20min,
programmed 1000rpm for 15sec every 4min. Beads were washed with 1x with
1XPNK, 1x with 1XPNK/EGTA (50mM Tris‐Cl pH 7.4, 20mM EGTA, 0.5% NP‐40)
and 2x with 1XPNK.
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Hot 3’ RNA linker ligation (on bead)
3’ RNA linker, L33 without 5’ phosphate, was 5’ radiolabeled with T4
phosphonucleotide kinase (PNK). 1ul of L33 no phosphate at 50pmol/ul, 15ul P32‐
γ‐ATP, 6ul of T4 PNK (NEB), and 2ul RNasin (Promega) in PNK buffer (NEB)
were incubated at 37oC for 30min. The reaction was let go for additional 5min
with 10ul 1mM ATP. Radiolabeled 3’RNA was then spun through a G25 column
(Amersham) to remove free ATP. Each 10pmol of the labeled 3’ RNA linker were
used for ligation reaction for one tube of beads, in addition, 8ul of 10X T4 RNA
ligase buffer (Fermentas), 8ul of BSA (0.2ug/ul), 8ul 10mM ATP, 2ul T4 RNA
ligase (Fermentas), 2ul of RNasin (Promega) and H2O up to total volume of 80ul
were added. On bead ligation reactions were incubated at 16oC for 1hr at
Thermomixer R programmed 1000rpm for 15sec every 4min. After 1hr, 4ul of
3’RNA linker, L33 with 5’ phosphate at 20pmol/ul were added to each tube of
reaction and incubation was continued over night. The next day beads were
washed 3x with 1XPNK.

PNK treatment (on bead)
80ul of PNK mix (1ul 10mM ATP, 4ul T4 PNK enzyme (NEB), 2ul RNasin and
8ul of 10XPNK buffer (NEB), H2O up to 80ul) were added to each tube. Mixture
was incubated for 20min 1000rpm 15sec every 4min and washed 3x with 1XPNK.
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SDS‐PAGE and transfer to nitrocellulose
Each tube of beads was resuspended in 13ul of LDS NuPAGE loading buffer
(Invitrogen), 4ul of 10X reducing agent (Invitrogen) and 13ul 1XPNK and
incubated at 70oC for 10min at 1000rpm. Supernatant were taken off the beads for
loading to Novex NuPAGE 10% Bis‐Tris gel (Invitrogen). After running at 175V
for 3hr, the protein gel was transferred to S&S BA‐85 nitrocellulose using Novex
wet transfer apparatus (Invitrogen). After transfer, nitrocellulose was quickly
rinsed with PBS, blotted with Kimwipes, wrapped in plastic wrap and exposed
to film. Most of radiolabeled unligated L33 linker would run close with the gel
front. Free RNA ligated with L33 linker, which would have an average size of 70
nt, will migrate on the gel mostly between 10‐30kD. Using 1:10000 RNase A
dilution would generate RNAs of average size of 50 nt. As the tags contained 20
nt long L33 linker, their average size would be 70 nt. Thus with our RNase A
digest, FMRP‐RNA complex would migrate on average approximately 20kD
higher than the molecular weight of FMRP alone due to the bound RNA tags.
Because RNase digestion is random, RNA tag sizes could vary from 30‐150 nt,.

41

RNA isolation and purification
Each band of nitrocellulose membrane was further cut into smaller pieces and
proteinase K treated (200ul of 4mg/ml of proteinase K (Roche) in 1XPK buffer
(100mM Tris‐Cl pH 7.5, 50mM NaCl, 10mM EDTA)) at 37oC, 1100rpm for 20min.
Then 200ul of 1XPK+7M urea solution were added and incubated for another
20min at 37oC 1100rpm. Finally, 400ul RNA phenol (Ambion) and 130ul of 49:1
CHCl3:isoamyl alcohol were added and incubated at 37oC, 1100rpm for
additional 20min. Tubes were spun at 20000xg in desktop microcentrifuge and
aqueous phase is carefully taken. 0.5ul of glycogen (Ambion), 50ul 3M NaOAc
pH 5.2 and 1ml of 1:1 ethanol:isopropanol were added and RNAs were
precipitated overnight at ‐20oC.

5’ RNA linker ligation
RNAs were spun down, washed; pellet dried and dissolved in 6ul H2O. RNA
ligation was performed with 1ul 10X T4 RNA ligase buffer (Fermentas), 1ul BSA
(0.2ug/ul), 1ul ATP (10mM), 0.1ul T4 RNA ligase, 3U (Fermentas), 1ul L51 RNA
linker at 20pmol/ul and 6ul of RNA in H2O at 16oC overnight.
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DNase treatment and RT‐PCR
To the ligation reaction, 77ul H2O, 11ul 10X RQ1 DNase buffer, 5ul RQ1 DNase
(Promega) and 5ul RNasin (Promega) were added and incubated at 37oC for
20min. 300ul H2O, 300ul RNA phenol (Ambion) and 100ul CHCl3 were added,
vortexed, spun and aqueous layer taken. RNAs were precipitated with 50ul 3M
NaOAc pH 5.2, 1ul glycogen (Ambion) and 1ml 1:1 ethanol:isopropanol over
night at ‐20oC. Next day, RNAs were spun down, pellet was washed, dried, and
resuspended in 8ul of H2O. 8ul of RNA were mixed with 2ul of P33 at 5pmol/ul,
incubated at 65oC for 5min, chilled, and spun. 3ul 3mM dNTPs, 1ul 0.1M DTT,
4ul 5X SuperScript RT buffer, 1ul RNasin, and 1ul SuperScript III (Invitrogen)
were added and incubated at 50oC for 30min, 90oC for 5min and left at 4oC. PCR
reactions were performed with 27ul Accuprime pfx supermix (Invitrogen), 1ul
P51 primer, 5pmol/ul, 1ul of P33 primer, 5pmol/ul and 2ul of the RT reaction,
cycled 20‐25 cycles with 95oC 20sec, 61oC 30sec, and 68oC 20sec.

Polyacrylamide gel separation of RNA
A 10% denaturing polyacrylamide was poured and the entire PCR reaction was
run. 3ul Amplisize Molecular Ruler (Biorad) were used. To visualize DNA, the
gel was immersed in 10000‐fold dilution of SYBR Gold (Molecular Probes) in TBE
for 10min. DNA of 60‐100 nts was cut out. DNA was extracted with Qiaex II kit

43

(protocol for polyacrylamide gel) (Qiagen) and resuspended in 15ul of H2O.
Finally they were re‐PCR with 454 Adapter Sequences or Solexa Fusion Primers.

Linker and primer sequences
RNA linkers (from Dharmacon):
R51: 5’‐OH AGG GAG GAC GAU GCG G 3’‐OH
R33: 5’‐P CGG UUG CGA GGU GAG UGA A 3’‐puromycin
R33 no P: 5’‐OH CGG UUG CGA GGU GAG UGA A 3’‐puromycin

454 Adapter Sequences:
Adapter A: 5’‐GCCTCCCTCGCGCCATC‐3’
Adapter B: 5’‐GCCTTGCCAGCCCGCTCAG‐3’

DNA primers (from Operon):
P51: AGGGAGGACGATGCGG
P33: CTTCACTCACCTCGCAACCG

Solexa Fusion Primers (from Operon):
DSFP5:5ʹAATGATACGGCGACCACCGACTATGGATACTTAGTCAGGGAGG
ACGATGCGG‐3ʹ
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DSFP3: 5ʹ‐CAAGCAGAAGACGGCATACGACCGCTGGAAGTGACTGACAC‐3ʹ
Solexa Sequencing Primer (from Operon):
SSP1: 5ʹ‐CTA TGG ATA CTT AGT CAG GGA GGA CGA TGC GG‐3ʹ

Ago CLIP in miR‐124 transfected HeLa cell.
HeLa cells were transfected using Lipofectamine 2000 (InVitrogen) in 100 mm2
plates with 75 nM RNA duplexes, miR‐124 and control miRNA from meridian
miRNA Mimic (Dharmacon). After 24hr, cells were harvested and CLIP.
Experiments were performed in two biological replicates using either 2A8 or
7G1‐1 antibodies. Degenerate barcodes (4 nucleotides tags) were introduced in
the 5ʹ fusion linker to increase the complexity in unique tags and to avoid
artifacts from preferential PCR duplication.

Exon arrays in P13 mouse brain.
For estimating the level of brain transcripts, total RNAs from three P13 mouse
brains were extracted using Trizol and RNAeasy kit and mRNA was amplified
and labeled by the method provided by Affymetrix. Mouse MoEx 1.0ST Arrays
were used for measuring signal intensity of each exon in the samples. To process
the signals from the array, quantile normalization and PM‐GCBG (signal
adjustment based on the background with similar GC content) were applied. The

45

IterPLIER method was used for selecting appropriate “core exon” probes to
estimate gene‐level intensities.

The presence of transcript in the P13 brain was

determined by the p‐value derived from DABG method (detection above
background, P<0.05) and genes with more than 100 in final total probe intensity
were selected. Finally, median log2 values from three biological replicates are
used to estimate level of transcripts in the P13 brain. Analyses were performed
by using Affymetrix Power Tools.

HITS‐CLIP data analysis
General bioinformatic analysis of CLIP tags.
CLIP tags were aligned to mm8 genome using BLAT and to miRNAs from
miRBASE (http://microrna.sanger.ac.uk) using BLAST, further visualized and
analyzed with UCSC genome browser (http://genome.ucsc.edu/) and Galaxy
(http://galaxy.psu.edu). General bioinformatics analysis including in silico
random

CLIP

were

performed

as

Python

script

utilizing

BioPython

(http://biopython.org); linear regression analysis for motifs by MatrixREDUCE
(http://bussemaker.bio.columbia.edu/software/MatrixREDUCE/);

microarray

data for miR‐124 targets from GEO database (http://www.ncbi.nlm.nih.gov/geo);
microarray analysis by BioConductor (http://www.bioconductor.org/); statistical
tests by Scipy (http://www.scipy.org/).
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Normalization of CLIP tags using in silico random CLIP algorithm.
Assuming that number of CLIP tags from transient nonspecific protein‐RNA
interactions are correlated with transcript abundance, then each transcript
should have different threshold level to differentiate signal:noise. Therefore we
estimated the false discovery rate (FDR) of CLIP tag clusters for each brain
transcript using a simulation method named in silico random CLIP. Transcript
abundance was measured by exon arrays (Affymetrix MoEx 1.0 ST, at the same
age (P13) and tissue (mouse brain) used for HITS‐CLIP). For simulating
transcript abundance, a number for each brain transcript (Nn) was assigned using
the normalized probe intensity from the microarray. RNase treatment was
simulated by introducing cleavage at a random site in each population of
transcript in given length (Yn; determined by RefSeq annotation) and this process
was repeated until an average length of 50 +/‐ 2 nt fragments was obtained. 50 nt
was determined based on the observation of mean 50 nt size of Ago‐mRNA CLIP
tags. When normalized to length and abundance, the number of fragments per
transcript Fn = Nn x Yn / 50. The total number of fragments per transcriptome
Tot(F) is the sum of Fn for all transcripts.

To simulate immunoprecipitation of nonspecific and transient RNA‐protein
interactions, we first calculated the expected number of tags for a transcript
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based on Fn and the total number of unique CLIP tags in that experiment. Thus
for a given CLIP experiment, we calculated the expected number of tags in any
given transcript (Tn), by multiplying total number of unique tags from actual
CLIP experiments (Z) with fraction of fragments for that transcript (Fn/Tot(F)).
We then randomly selected Tn fragments for each transcript, and these were
aligned with their position in the given transcript. If the selected fragment was
more than 36 nt, the 3’ end of the fragment was eliminated to leave only 36 nt to
simulate an Illumina sequencing read. We calculated the maximum background
cluster height (Mn, maximum number of overlapping tags) from the alignment,
and repeated this simulation repeated 500 times for every transcript. FDR (P‐
value) was determined by counting the observed number of maximum clusters
(Mn) from each of 500 repeats, and the cluster height giving p<0.01 in each
transcript was used as threshold for normalization of HITS‐CLIP cluster. In this
way, the normalization for HITS‐CLIP varied for each transcript according to its
abundance, length, and its simulated background cluster height. The alogorithm
was implemented in python script by utilizing the cubic spline modules in Scipy
( interpolate.splrep(), interpolate.splev() ).
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Ranking of Ago‐miRNA CLIP tags.
The ranking of miRNAs is based on the frequency of each ~22 nt sequences in
Ago‐miRNA tags. Where multiple members of family of miRNAs have identical
seeds, we did analyses of the family in aggregate, summing the frequency of
each member.

Normalization of Ago‐mRNA clusters along transcripts
To normalize for differences in the length of transcripts in the CDS and 3’ UTR,
the number of clusters at each position was divided by the total number of
transcripts at that position (blue graph). The standard deviation of fraction in
each position was estimated based on the assumption that prediction result is
binomial distribution (drawn as light blue graph). To determine whether the
different length of transcripts biased the position of clusters, the position of a
cluster within each transcript was randomly redistributed.

Distribution of tags relative to cluster peaks
We plotted the distribution of Ago‐mRNA tags within clusters. To compensate
for differences in the number of CLIP tags present in different clusters, we
randomly chose 30 tags from each of the 61 most robust clusters (single peak, BC
= 5, and > 30 tags per peak) or 135 robust clusters (BC=5, > 30 tags per peak). The
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peak of each cluster was determined by cubic spline interpolation analysis, and
the distribution of tags relative to the peak was plotted). For the distribution of
miRNA binding sites in 135 robust clusters, conserved seed sites (position 2‐7) of
top 30 miRNAs and bottom 30 miRNAs were searched in Ago CLIP cluster
regions and plotted as the relative position from the peaks. If width of an Ago
CLIP cluster was more than 100nt from the peak, we restricted the search within
+/‐ 100nt window from the peaks.

To determine the distribution of conserved miR124 seed sites (6mers in position
2‐8) in Ago‐mRNA clusters (BC > 2), we first determined the number of clusters
as a function of relative position from the peak. Because of the variability in the
width of AGO CLIP cluster, the number of predicted conserved mir‐124 target
sites in each relative position from the peak of the cluster was divided by the
number of clusters in each position and indicated as fraction. Standard deviation
of fraction in each position was estimated based on the assumption that
prediction result is binomial distribution

Cluster peak analysis using cubic spline interpolation.
Based on the position of tags in genome, the number of unique tags in each
nucleotide position was calculated for all AGO‐mRNA CLIP clusters. Cubic
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spline interpolation method was applied to interpolate tag density in the clusters
by using Scipy (http://www.scipy.org/). By determining the derivative of the
function at each point of the interpolation, locating the point where the
derivative = 0, and confirming that the derivative changes from positive to
negative around this point, the location and number of peaks per cluster were
determined.

Excess

kurtosis

was

determined

using

Scipy

(http://www.scipy.org/).

Prediction of miRNA binding sites
Based on the observation that enriched 6‐8 mer seed sequences were present in
the Ago footprint region, we identified all 6‐mer sequences in miRNA seed
position 1‐8 to identify candidate 6‐8 mer miRNA binding sites. For selecting
conserved

sites,

Multiz8way

results

from

UCSC

genome

browser

(http://genome.ucsc.edu) were used to search for seed sites that were conserved
across more than 4 of 5 species (human, mouse, rat, dog, chicken). Predicted
miRNA binding sites were downloaded from databases available from the
following websites, using precompiled batch results and default parameters set
by the developers of each algorithm; miRBase (http://microrna.sanger.ac.uk/ ,
miRanda

algorithm,

Sep

2008

version),

TargetScan

4.1

(http://www.targetscan.org/ downloading mm8 bed format files from the www
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site), PicTar4 (predictions in human were obtained from UCSC genome browser
and

converted

to

mouse

by

the

liftOver

(http://genie.weizmann.ac.il/pubs/mir07/index.html,

TOP

program),

PITA

prediction),

and

RNA223 (http://cbcsrv.watson.ibm.com/rna22.html, precompiled data for the
3’UTR of mouse transcripts (with parameters: G=0 M=14 E=‐25Kcal/mol) were
mapped to mouse genome by ELAND (Efficient Large‐Scale Alignment of
Nucleotide Databases; provided by Illumina)).

Meta‐analysis of microarray studies.
Raw data or normalized data from 5 microarray studies in miR‐124
overexpression

(Table

5.4)

were

obtained

from

GEO

database

(http://www.ncbi.nlm.nih.gov/geo). Raw data were normalized by the same
method used in each study and finally log2 ratio for each transcript, which is the
median value in all replicates and probes, was calculated only if its change is
statistically significant (P< 0.05, t‐test). For the meta‐analysis of data to compare it
with Ago CLIP, only transcripts showing robust change (P<0.05) at least 2 times
in 5 studies without any significant opposite fold change were selected. Among
these transcripts, 1278 brain expressed transcripts were further selected based on
exon array result in P13 mouse brain (10743 genes, p<0.05 (DABG), normalized
probe intensity >100). To compare the cumulative fraction depending on fold
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change,

Kolmogorov‐Smirnov

test

was

performed

using

Scipy

(http://www.scipy.org/).

Gene ontology analysis
Gene

ontology

analysis

was

done
or

(http://discover.nci.nih.gov/gominer/)
(http://david.abcc.ncifcrf.gov/).
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using
using

GoMiner
DAVID

CHAPTER III. GENOME‐WIDE ANALYSIS OF RNA‐
PROTEIN INTERACTIONS FOR NOVA

Introduction
Nova is an onconeural antigen targeted in patients with paraneoplastic
opsoclonus myoclonus ataxia (POMA), a syndrome is characterized by abnormal
motor inhibition (originally termed Ri) (Buckanovich et al., 1996). Nova contains
three functional KH‐type RNA‐binding domains and functions as a brain specific
splicing factor which regulates the splicing of target RNAs (Buckanovich and
Darnell, 1997). A specific sequence element, YCAY tetramer (where Y indicates a
pyrimidine, U or C ) was identified as a Nova RNA ligand by in vitro RNA
selection (Jensen et al., 2000b), X‐ray crystallography (Lewis et al., 2000) and
further confirmed by CLIP (in vivo cross‐linking and immunoprecipitation) (Ule
et al., 2003). In addition, studies with custom splicing microarrays from
Affymetrix elucidated that Nova regulates the splicing of target RNAs encoding
proteins that function mostly at the synapse (Ule et al., 2005b).

We have taken a different approach towards understanding protein–RNA
interactions for studying Nova. A major breakthrough of the studies is
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developing a crosslinking protocol that works in tissues, and can therefore be
applied before protein purification (Jensen and Darnell, 2008; Ule et al., 2005a;
Ule et al., 2003). This method, called “CLIP”, involves covalent trapping of RNA‐
protein complexes in intact cells by irradiating them with UV‐B light (~256 nM),
and subsequently purification of the complexes of which RNA is digested into
the size of a small nucleic acid fragment called “tag” under stringent conditions
(Ule et al., 2003). CLIP has been used to study direct protein–RNA interactions
extant in living cells, including identification of RNA targets for Nova and the
discovery of hnRNPA1‐dependent regulation of a microRNA.(Guil and Caceres,
2007).

To comprehensively understand functional network of Nova target RNAs and
yield genome wide insight into Nova‐RNA interactions, a new high‐throughput
target identification system is attempted to be developed based on the
application of CLIP method to high‐throughput sequencing in this study. This
method uses newly available pyrosequencing technology that sequences all tags
isolated from CLIP procedure, by reading a fibre‐optic slide of individual wells,
where each tag is amplified using an emulsion method and is extended for
sequencing in the solid support (Thomas et al., 2003). This method can read 25
million bases, at 99% or better accuracy, in one four‐hour run. Here we
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demonstrate that this approach confirms and generalizes the previous
knowledge of Nova biology by generating massive information about in vivo
target sites with high resolution and further uncovers global insight into RNA
regulations by Nova, which regulates processing of some miRNAs. Development
of HITS‐CLIP is important in that it can be used as general platform to indentify
functional RNA‐protein interactions and yield genome‐wide insight for the
discovery of new biology.

Results
Development of HITS‐CLIP for Nova.
To comprehensively understand genome‐wide Nova action on target RNAs, a
new high‐throughput target identification system was developed based on
massive parallel sequencing called HITS‐CLIP (high‐throughput sequencing
CLIP; Figure 3.1). The Nova HITS‐CLIP experiment, performed in P13 mouse
brain, identified 15,300 unique tags from the ~75 kD band of Nova‐RNA complex,
11,701 unique tags from the ~90kD band of high molecular weight Nova‐RNA
compelx (Super Nova‐RNA complex), and 43,445 control unique tags from the
supernatant after immunoprecipitation, which can be used as a control set
(Figure 3.2). Derivatives of YCAY motif were identified as the most enriched
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motifs (among all possible 4mers, 5mers and 6mers including degeneracy letter)
in Nova HITS‐CLIP tags by comparing its frequency in Nova sets with it in
control sets or random shuffled sequence sets (Figure 3.3). For further
identification,

two

critical

values

were

calculated

and

considered

in

bioinformatics analysis. One is the log‐odd ratio value derived from calculating
motif frequency in Nova tags divided by the frequency in control tags. The other
is the percentage of tags containing each specific motif (Figure 3.4). Interestingly,
bioinformatics results of the motif identification showed few enriched motifs
without YCAY, and most motifs were subset of an YCAY cluster (Figure 3.4C). In
addition, bioinformatics analysis of YCAY motifs in Nova tags supports the
hypothesis that the RNA binding element of Nova forms as YCAY clusters,
multimers of the YCAY tetramer (Dredge and Darnell, 2003) (Figure 3.5). Taken
together, these data support the biological relevance of Nova HITS‐CLIP data to
our previous knowledge of Nova biology, indicating that HITS‐CLIP can be used
as a platform to identify comprehensive in vivo binding sites of a given RNA
binding protein and yield genome‐wide insight into RNA regulations.

Nova HITS‐CLIP tags are enriched in introns and non‐coding RNAs
After alignment of Nova HITS‐CLIP tags to the mouse genome (mm8, Build 36
assembly by NCBI and the Mouse Genome Sequencing Consortium), the
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distribution of tags in the genome was examined based on the RefSeq and
KnownGene annotation. Annotation of the tags (Figure 3.6A) showed that most
tags (54%) are from introns, consistent with results from analysis of Nova’s role
in splicing. 19% of tags are from exonic regions and among them 15% of tags are
from 3’UTRs, where Nova might regulate processing of 3’UTR such as
polyadenylation, translation, or stability of the transcripts. The remaining tags
are from ESTs (12%), repeated sequences (10%) or non‐annotated regions (4%),
which can be putative non‐coding RNAs having important regulatory roles. In
total 26% of tags are from putative non‐coding RNAs, which is the second most
enriched categories after intron (54%), suggesting that Nova may have function
in non‐coding RNA regulation (Figure 3.6A). Interestingly, a maternally
expressed non‐coding RNA, gtl2 has the highest number of HITS‐CLIP tags (471
reads/100bp, 800 total tags), including downstream tags in many non‐coding
RNA clusters including miRNA clusters (Seitz et al., 2004) and C/D snoRNA
clusters (Figure 3.6B‐D). A genome wide YCAY cluster search was performed by
measuring YCAY density (reads/100bp) and the highest peak of YCAY density in
gtl2 intron overlaps with the highest peak of the tags (reads/100bp), suggesting
specific binding and perhaps alternative splicing of gtl2 (Figure 3.7A). By
performing RT‐PCR analysis of brain RNAs from Nova DKO (Nova1 ‐/‐ and
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Nova2 ‐/‐) mice versus wild type mice, the 3’end exon of gtl2 was confirmed to
be alternatively spliced depending on Nova expression (Figure 3.7A‐B).

Nova regulates processing of some miRNAs in gtl2 region
Among miRNAs in gtl2 region, mir‐770 locates in the gtl2 intron. To assess the
effect of Nova on miR‐770 levels, Q‐PCR (quantitative real‐time PCR)(Chen et al.,
2005; Shi and Chiang, 2005) was used to measure each splicing form of gtl2 as
well as each processed form of miR‐770 ( unprocessed pri‐miR‐770, processed
pri‐miR‐770 and mature miR‐770), generated during miRNA processing (Figure
3.7C‐D). Every form generated during mir‐770 processing was down‐regulated
in forebrain of Nova2 KO mice, showing that it correlates with the down‐
regulation of the gtl2 splicing variant harboring miR‐770 in Nova2 null mice
(Figure 3.7E). The process of this miR‐770 containing variant may be enhanced
by two regulatory mechanisms, Nova dependent alternative splicing and
polyadenylation (Figure 3.7). Mir‐380, another miRNA in a second miRNA
cluster downstream of the gtl2 transcript, was also investigated by the same
experimental

method

(RT‐PCR

and

Q‐PCR;

Figure

3.9).

Surprisingly,

unprocessed pri‐mir‐380 is increased but mature mir‐380 is decreased in the
Nova2 KO, suggesting that Nova may regulate processing step of pri‐mir‐380,
known to be performed by Drosha complex (Lee et al., 2003) (Figure 3.9). This
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result correlates with recent observation of post‐transcriptional regulation in
miRNAs processing, which has been implicated in cancer (Thomson et al., 2006).
In adition, more miRNAs in the gtl2 region (~20 miRNAs) or several regions
other than gtl2 (~15 miRNAs) were found to have Nova‐CLIP tags in their
vicinity (≤1kb). Therefore, the effect of Nova on the processing of these miRNAs
is worth further investigation by the same validation approaches, with the
potential to find general rules for Nova dependant regulation of miRNA
processing

Discussion
Genome‐wide screens have been used to suggest correlations between the action
of RNABPs and biologic diversity (Keene, 2007), but are unable to identify direct
sites of RNA regulation. HITS‐CLIP provides a general solution to this problem
by generating a transcriptome‐wide biochemical “footprints” of protein‐RNA
interactions in living tissues. This in turn allows a direct comparison of predicted
(e.g. microarray or bioinformatically derived) and observed (HITS‐CLIP) sites of
action, and thereby provides a new platform for deriving functional RNABP
maps. HITS‐CLIP extends our transcriptome‐wide understanding of Nova‐RNA
interactions, which was previously limited to bioinformatic analysis of YCAY
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clusters within 200nt of alternate or bounding constitutive exons (Ule et al., 2006).
Importantly, bioinformatics analysis on Nova HITS‐CLIP map strongly correlates
with our previous findings about Nova, suggesting that the map is sufficiently
robust to predict protein‐RNA regulation.

The unbiased nature of HITS‐CLIP led to the unexpected identification of Nova
binding in non‐coding RNAs, including primary transcripts encoding miRNAs
and the recognition of its role in regulating processing of miRNAs in the brain.
The presence of such processing factors was postulated after the recognition of
discrepancy between pri‐miRNA and mature miRNA level and observation that
post‐transcriptional regulation in miRNAs processing is regulated in caner cell
(Thomson et al., 2006).

In summary, HITS‐CLIP offers a powerful new platform for studying RNA
regulation in vivo. This genome‐wide biochemical approach complements
bioinformatic, microarray and genetic studies. HITS‐CLIP is able to identify
biologically relevant interactions, providing a focus on direct protein‐RNA
contacts as critical points for understanding RNABP function. The unbiased
nature of the platform holds the potential for new discovery, including regulated
RNA substrates. Identifying Nova as the potentail vertebrate factor to regulate
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miRNA processing in mouse brain demonstrates that a single factor can regulate
different aspects of tissue‐specific RNA and miRNA metabolism

Contributions
Bioinformatic analysis, isolation of RNA from Nova‐/‐ mice, RT‐PCR and Q‐PCR
were done by Sung Wook Chi. Nova HITS‐CLIP experiments were performed by
Aldo Mele. HITS‐CLIP analysis was developed by Sung Wook Chi, Robert B.
Darnell, Donny D. Licatalosi, Jennifer C. Darnell and Aldo Mele. Jernej Ule
discovered that gtl2 alternative splicing was Nova‐dependent.
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Figure 3.1. HITS‐CLIP procedure.

CLIP takes advantage of the ability of UV‐irradiation to directly penetrate intact
cells or tissues and induce covalent crosslinks between RNA and proteins that
are in direct contact (~1 Ångstrom distance). Once covalently bound, complexes
can be purified under harsh conditions, with three key advantages:

these

conditions separate closely bound RNABP‐RNABP complexes, reassociated
RNAs, and background RNA.

After purification, the CLIP method utilizes

proteinase K to remove the RNABP, linker ligation and RT‐PCR to analyze RNA
sequencing, which can be done using high throughput sequencing methods
“HITS‐CLIP”. (CLIP procedure figures are attributed to Jernej Ule)
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Figure 3.1
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Figure 3.2. Nova HITS‐CLIP

A. Postnatal day 9 mouse cortex tissue was UV irradiated, protein‐RNA
complexes immunoprecipitated with Nova antiserum and confirmed the size of
two forms of Nova2 (~50kD Nova and ~70kD SuperNova). RNA‐protein
complexes from immunoprecipitation labeled with
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P and separated by SDS‐

PAGE and transferred to nitrocellulose and visualized by autoradiography. CLIP
revealed ~90kD SuperNova‐RNA complex and ~75kD Nova1‐RNA complex. B.
From the nitrocellulose membrane, the two bands indicated with squared in
panel A were cut out, the RNA purified, and amplified with RT‐PCR.
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Figure 3.2
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Figure 3.3. Identification of enriched motifs in Nova HITS‐CLIP tags.

A.The log‐odds ratio of the number of the motif in Nova HITS‐CLIP tags to the
number of the motifs in shuffled sequence or control tags were plotted for all
combinations of 4mer motifs including degenerate letters ( n = 50626 ).
Statistically significant motifs enriched in Nova HITS‐CLIP tags are indicated as
blue circle ( Log2(Nova/Shuffle) > 1, Log2(Nova/Control) > 1, P < 0.01 ). B. Top 6
ranked motifs depending on p‐value.
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Figure 3.3
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Figure 3.4. Identification of enriched motifs in Nova HITS‐CLIP tags.

A. The log‐odds ratio of the number of the motif in Nova HITS‐CLIP tags to the
number of the motifs in control tags were plotted in x‐axis and percentage of
nova tags containing the motifs were plotted in y‐axis for all the combination of
5mer motifs. Statistically significant motifs enriched in Nova HITS‐CLIP tags are
indicated as blue dots. Top 25 ranked motifs containing an YCAY motif B and
without YCAY motif C.
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Figure 3.4
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Figure 3.5. Identification of enriched motifs in Nova HITS‐CLIP tags.

A. Percentage of the tags containing different numbers of YCAYs are calculated
in Nova, control and shuffled HITS‐CLIP tags. B. The shortest distance between
YCAY motifs are calculated in the tags including Nova,control and shuffle HITS‐
CLIP tags. 65.7% of the Nova tags contains YCAY cluster with less than the 5
nucleotide distance. (34.1% in the control and 38.1% in the shuffled tags)
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Figure 3.6. Genome wide distribution of Nova HITS‐CLIP tags.

A. Pie chart representation of Nova HITS‐CLIP annotation. Two databases
(RefSeq and KnownGene) are used for the annotation of the tags. B. Number of
Nova HITS‐CLIP tags in 100bp windows are calculated. BLAT search is used to
get the genomic coordination of mouse. C. Distribution of Nova HITS‐CLIP tags
in chromosome 12, where gtl2 is located. D. Distribution of the tags in gtl2 region
(mm8, chr12:109,981,359‐110,222,678) . Location of tags in genome is indicated as
green bar together with bar graph with number of tags per 100bp in Y‐axis.
Transcript of gtl2 is displayed as blue arrow.Location of miRNAs in miRNA
clusers are also indicated as red bar and C/D snoRNAs are represented as black
bar.
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Figure 3.7. Nova dependant alternative splicing of gtl2 and production of miR‐
770.

A. Gene structure of gtl2. Red or blue dot indicates the alternative splicing
produt of gtl2 gene. Distribution of Nova‐HITS tags are plotted as green and
YCAY density (Reads/120bp) is also plotted as black. Location of mir‐770 in gtl2
transcript is represented as red bar. B. Ratio of two‐alternative splicing products
(gtl2L and gtl2S) are measured by RT‐PCR in the total RNA from wild type
mouse brain (WT) versus Nova double knock‐out mouse brain (DKO). C.
Schematics of miRNA processing with location of PCR primers, used to measure
the each processing product by quantitative real time PCR (Q‐PCR). D. The
amount of two alternative splicing forms of gtl2 is measured by Q‐PCR. Ratio
between values from WT and Nova2 knock out mouse forebrain (N2KO) is
plotted as Y‐axis. The amount of actin transcript is used for normalization. E. The
amount of various products generated during miRNA processing is measured by
Q‐PCR (Un: unprocessed pri‐miRNA, Pri: pri‐miRNA, Ma: mature miRNA). Mir‐
25, which has no tags and no YCAY cluster in its vicinity, is used as control. For
normalization, the amount of U6 is measured to obtain a ΔCT value.
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Figure 3.8. Nova dependant processing of miR‐380.

A. Location of a Nova‐CLIP tag in the primary transcript of miR‐380 is indicated
as green bar and miR‐380 is displayed as red bar. PCR products amplified for
measuring each processing product of miR‐380 are indicated (Un: unprocessed
pri‐miRNA, Pri: pri‐miRNA, Ma: mature miRNA). B. The amount of various
products generated during miRNA processing is measured in miR‐380 and miR‐
25. miR‐25, which has no tags and no YCAY clusters in its vicinity, is used as
control. For normalization, the amount of U6 is measured to obtain a ΔCT value.
Ratio between the values from WT and Nova2 knock out mouse forebrain
(N2KO) is plotted in Y‐axis as relative expression. C. Various products generated
during miR‐380 and miR‐25 processing are amplified by RT‐PCR in the total
RNA from wild type mouse forebrain (WT) versus Nova2 null mouse forebrain
(N2K).
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CHAPTER IV. GENOME‐WIDE INDENTIFICATION OF
ARGONAUTE ASSOCIATED RNAS

Introduction
The limited number of primary transcripts in the mammalian genome has
promoted interest in the possibility that much of the complexity in the regulation
of gene expression may be determined by regulation of RNA metabolism and
expression. MicroRNAs (miRNAs) underscore this possibility, as they directly
bind to many mRNA to regulate their translation or stability (Filipowicz et al.,
2008; Shyu et al., 2008), and thereby regulate a wide range of activities, including
development, immune function and neuronal biology (Ambros, 2004; Bartel,
2004; He and Hannon, 2004).

Many miRNAs are evolutionarily conserved,

although others are species‐specific (including human miRNAs not conserved in
chimpanzees) (Berezikov, 2006), consistent with wide roles for miRNAs, from
regulating basic cellular functions to generating organismal diversity.

We have developed HITS‐CLIP to directly identify protein‐RNA interactions in
living tissues and in a genome‐wide manner (Licatalosi et al., 2008; Ule et al.,
2003).

This method (Jensen and Darnell, 2008; Ule et al., 2005a) uses UV‐
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irradiation to covalently crosslink RNA‐protein complexes that are in direct
contact (~ single Angstrom distances) within cells, allowing RNA‐protein
complexes to be stringently purified. Partial RNA digestion reduces bound RNA
to small fragments that can be sequenced by high throughput methods, yielding
genome‐wide information regarding the sites of the RNA‐protein interactions
(Licatalosi et al., 2008; Yeo, 2009). Recent X‐Ray crystal structures of a ternary
complex of a core RISC component, Argonaute (Ago), bound to both a 21‐mer
DNA guide strand (miRNA equivalent) and a 12 nt fragment of complementary
mRNA (Wang et al., 2008a) suggest that Ago may make sufficiently close
contacts with both nucleic acid strands to allow Ago HITS‐CLIP to
simultaneously identify Ago bound miRNAs and the nearby mRNA sites. Here
we developed Ago HITS‐CLIP analysis to identify Ago associated brain RNAs in
genome wide manner. This provides a platform that can establish the direct
targets upon which miRNAs act in a variety of biologic contexts, and the rules by
which they do so.
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Results
Immunoprecipitation of Argonaute complexes
HITS‐CLIP experiments rely on a means of purifying RNA binding proteins
(RNABPs) (Jensen and Darnell, 2008; Licatalosi et al., 2008; Ule et al., 2005a; Ule
et al., 2003). To purify endogeneous Ago complexes, we performed
immunoprecipitation (IP) using two different Ago antibodies, 7G1‐1* and 2A8.
Experiments using the 7G1‐1* antibody were undertaken after recognizing that
this monoclonal antibody, obtained from the Iowa Developmental Hybridoma
(IDH) bank, were a mixture of clones of anti‐FMRP antibody and anti‐Ago
antibody, an observation confirmed by mass‐ spectrometry sequencing of
immunoprecipitated products in WT and FMRP KO brain (Figure 4.1), and
confirmed independently (Z. Mourelatos, personal communication). Attempts to
subclone independent hybridoma clones from a different frozen batch of cells
(IDH) were not successful (as subsequent batches from IDH harbored only the
original 7G1‐1 clone). Specificity of Ago immunoprecipitation was confirmed in
both experiments using 2A8 and 7G1‐1 (Figure 4.1).

Development of Ago HITS‐CLIP in mouse brain.
After confirming the specificity and efficiency of endogeneous Ago IP in mouse
brain lysates (Figure 4.1), Ago HITS‐CLIP was performed. To purify Ago bound
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to

mouse

brain

RNAs,

we

first

UV‐irradiated

P13

neocortex

and

immunoprecipitated Ago under stringent conditions with strong detergent (0.1%
SDS, 0.5% deoxycholate and 0.5% NP‐40) and high salt wash (upto 685mM
sodium chlrolide). Then we radiolabeled RNA, further purified crosslinked Ago‐
RNA complexes by SDS‐PAGE and nitrocellulose transfer, and visualized
complexes by autoradiography (Figure 4.2). HITS‐CLIP with the 2A8 antibody
(Nelson et al., 2007) was done in sibling P13 mice from freshly dissected
neocortex and HITS‐CLIP with the 7G1‐1* antibody done in WT P13 mouse brain
in the presence of blocking peptide (mapped to FMRP amino acid 354 to 368),
which has been demonstrated to block FMRP immunoprecipitation by 7G1‐1
(Brown et al., 2001). In addition, one experiment was done in sibling FMRP KO
P13 mouse brain, although only tags that were also present in independent
experiments were considered (Figure 4.1 and 4.6).

Interestingly, we observed complexes of two different modal sizes (~110 kD and
~130kD; Figure 4.1 and 4.2), suggesting that Ago (97kD) was crosslinked to two
different RNA species. RT‐PCR amplification revealed that the ~110 kD band
harbored ~22 nt crosslinked RNAs and upper band both 22 nt and larger
crosslinked RNAs (Figure 4.2C). Both products were sequenced with single
molecule sequencing methods (Licatalosi et al., 2008) and found to correspond to
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miRNAs and mRNAs, respectively (Table 4.1), suggesting that Ago might be
sufficiently close to both miRNA and target mRNAs to form crosslinks to the
ternary complex (Figure 4.2D). Such a result would allow the search for miRNA
binding sites to be constrained to both the subset of miRNAs directly bound by
Ago‐CLIP and to the local regions of mRNAs to which Ago crosslinks, thus
greatly reducing the rate of false positive predictions of miRNA binding.

Bioinformatic analysis of Ago‐miRNA CLIP data
After aligning the tags from 110kD to miRNA sequences, toal ~22 x 106 miRNA
tags are collected from 5 different biological replicates of Ago HITS‐CLIP
experiments (Table 4.1). We compared miRNAs by frequency with which they
were detected in Ago‐miRNA CLIP in five different experiments using two
different antibodies (Figure 4.3).

The set of Ago‐crosslinked miRNAs were

highly reproducible. Among biologic triplicates or 5 replicates done with two
antibodies, the Pearson correlation coefficient was R2 > 0.9 and > 0.83,
respectively, for Ago‐miRNA CLIP (Figure 4.3 and 4.10B). We identified 454
unique miRNAs crosslinked to Ago in mouse brain, with Ago‐miR‐30e being the
most abundant species (14% of total tags; Figure 4.3). The abundance of miRNAs
was generally consistent with previous estimates of miRNA frequency in brain
measured by cloning frequency (Landgraf, 2007) or bead‐based cytometry (Lu,
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2005), although the correlation with published results (R2 = 0.2 ‐ 0.32; Figure 4.4)
was not as high as among biologic replicates in our experiments. Some of the
differences between our data and published results might be due to differences
in the ages of brain used, regulation of Ago‐mRNA interactions, and/or increased
sensitivity allowed by the stringent conditions in CLIP which consequently
improved signal:noise ratio

Bioinformatic analysis of Ago‐mRNA CLIP data
After aligning the tags from the 130kD complex to mouse genome, toal ~1.5 x 106
unique tags are collected from 5 different biological replicates of Ago HITS‐CLIP
experiments (Table 4.1). To differentiate robust from non‐specific or transient
Ago‐RNA interactions, we compared the results from biologic replicate
experiments done with two different monoclonal antibodies (Figure 4.6). The
data was further refined by comparison with in silico random CLIP, an algorithm
designed to normalize for variation in transcript length, abundance, and
simulated background cluster height (Figure 4.5). The processing algorithm, in
silico random CLIP, simulates distribution of sequence tags across mRNAs based
on its expression, providing a background level for the number of tags that
would be expected by chance to simultaneously overlap one another, forming
clusters (Figure 4.5). For in silico random CLIP algorithm, abundance of
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transcripts in P13 mouse brain was measured by microarray and it is further
confirmed that normalized probe intensity values from microarray can be used
for in silico random CLIP simulation (Table 4.2). To facilitate the analysis of large
numbers of Ago‐mRNA CLIP tags (~1.5 x 106 unique tags; Table 4.1), we
analyzed overlapping tags (clusters), which were normalized by in silico random
CLIP and sorted by biologic complexity (Licatalosi et al., 2008) (“BC”; a measure
of reproducibility between biologic replicates; Figure. 4.5‐7).

1,463 robust

clusters (BC=5; i.e. harboring CLIP tags in all five biologic experiments using
both antibodies) mapped to 829 different brain transcripts, and 990 clusters had
at least 10 tags (Figure. 4.7). We also estimated that sequencing depth was near
saturation by simulation analysis (Figure 4.8). The set of Ago‐crosslinked
mRNAs were also highly reproducible. Among biologic triplicates or among 5
replicates done with two antibodies, the Pearson correlation coefficient was R2 >
0.8 and > 0.65, respectively, for Ago‐mRNA CLIP (Figure 4.9 and 4.10A).

Genomic distribution of Ago‐mRNA CLIP tags
The distribution of Ago‐mRNA CLIP tags in the genome showed enrichment in
transcribed sequences (Figure 4.10C).

The pattern of tags in mRNAs mirrored

functional assays with miRNAs (Grimson, 2007), which show no biologic activity
when seed sites are present in the 5’ UTR (1% Ago‐mRNA tags), and high
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efficacy in 3’ UTRs (40% tags including 8% within 10kb downstream of
annotated transcripts, regions likely to have unannotated 3’ UTRs (Licatalosi et
al., 2008; Wang, 2008). In addition, an extensive set of tags were identified in
other locations, including coding sequence (CDS; 25%), a site for which there is
emerging evidence of miRNA regulation (Duursma et al., 2008; Forman et al.,
2008; Lal, 2008; Shen et al., 2008; Tay et al., 2008), introns (12%), and non‐coding
RNAs (4%), suggesting the possibility that these sites may provide new insights
into diverse biologic roles for Ago proteins. Within mRNAs, tags present in
clusters were highly enriched in the 3’ UTR (~60%; Figure 4.11). Ago‐mRNA
clusters were highly enriched around stop codons (with a peak ~50 nt
downstream) and at the 3’ end of transcripts (~70 nt upstream of presumptive
poly(A) sites; P<0.003, Figure 4.10D), consistent with bioinformatic observations
from microarray data (Grimson, 2007). Taken together, this data supports the
biological relevance of Ago‐mRNA clusters and suggests that they may be
associated with functional binding sites.
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Discussion
Here, we developed Ago HITS‐CLIP to identify Ago associated RNAs, which are
miRNAs and target mRNAs. Our Ago HITS‐CLIP data provide a new approach
promising to solve the difficult problem of identifying functionally relevant
miRNA binding sites in living tissues. Several studies set the stage for the
development of Ago HITS‐CLIP as a way to possibly resolve the ambiguity of
what RNAs miRNAs target and where they bind to them in vivo.
Crystallographic structures of Ago‐miRNA (Wang et al., 2008b) and Ago‐target
mRNA‐miRNA ternary complexes (Wang et al., 2008a) have demonstrated close
contacts between all three molecules, underscoring the suggestion that CLIP,
which requires close protein‐RNA contacts (Jensen and Darnell, 2008; Ule et al.,
2005a), could identify Ago‐RNA ternary complexes.

High throughput

experimental approaches, together with increasingly powerful bioinformatics
technique shows robust and reproducible results across biological replicates of
Ago HITS‐CLIP and also shows relevant distribuction of mRNA tags along the
genome and transcripts to miRNA biology. Such results indicate that Ago HITS‐
CLIP can be used as the platform to identify miRNA binding sites in vivo.and
also would allow the search for miRNA binding sites to be constrained to both
the subset of miRNAs directly bound by Ago and to the local regions of mRNAs
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to which Ago crosslinked, potentially reducing the rate of false‐positive
predictions of miRNA binding.

Contributions
Ago HITS‐CLIP analysis was developed by Sung Wook Chi, Julie B. Zang, Aldo
Mele and Robert B. Darnell. Bioinformatic analysis, Ago HITS‐CLIP experiments
with the 2A8 antibody, and exon array experiments were done by Sung Wook
Chi. in silico random CLIP algorithm was also developed by Sung Wook Chi.
Characterization of 7G1‐1* antibody and initial Ago CLIP experiments with the
7G1‐1* antibody were performed by Julie B. Zang. Aldo Mele helped with all
HITS‐CLIP experiments. John J. Fak helped with microarray experiments. Scott
Dewell helped with high‐throughput sequencing (Illumina Genome Analyser).
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Figure 4.1. Immunoprecipitation of Ago complex with 7G1‐1* and 2A8
A. WT and FMRP KO mouse brain lysates were immunoprecipitated with either
7G1‐1* (containing monoclonal antibodies to both FMRP and Ago) or 7G1‐1
(containing only FMRP monoclonal antibody).

Immunoprecipitates were

analyzed by immunoblot probed with 7G1‐1* (left panel), anti‐Ago1 (right panel)
and anti‐Ago2 antibody (middle panel). Both 7G1‐1 and 7G1‐1* antibodies
immunoprecipitated FMRP (not in FMRP KO). 7G‐1* also IPed Ago1 and Ago2
at ~100 kD from both WT and KO recognized by anti‐Ago1 and anti‐Ago2
antibodies. B. 7G1‐1* immunoprecipitate from KO brain was run on SDS PAGE
and stained with Coomassie brilliant blue. Protein bands were analyzed with
mass spectrometry. Ago proteins 1‐4 were identified at ~100 kD. C. 7G1‐1*
antibody

was

pre‐incubated

with

200ug

of

FMRP

peptide

(354‐

KHLDTKENTHFSQPN‐368; the epitope of 7G1‐1* or an irrelevant control (FLAG
peptide). FMRP peptide, but not control peptide, was sufficient to completely
block FMRP immunoprecipitation from WT mouse brain and had no effect on
Ago immunoprecipitation.

D. 32P‐labeled RNA crosslinked to Ago and FMRP

immunoprecipiated with 7G1‐1* from WT or FMRP KO mice as indicated. The
antibody pulls down complexes of ~90kD, which correspond to FMRP, as
indicated by the disappearance of this band when IPs performed from FMRP KO
brains or in the presence of 200 ug of the competing peptide epitope. For HITS‐
CLIP experiments, two different animals were used, Brain “D” corresponds to
CLIP of WT brain done in the presence of peptide competition and isolated the
Ago band (D, lane 3), and Brain “E” corresponds to CLIP of FMRP KO brain (D,
lane 2). E. Replicate Ago CLIP with 2A8 monoclonal antibody. Overdigestion of
Ago RNA cross‐linked complex showed the protein size of Ago (~95kD)
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Figure 4. 2. Argonaute HITS‐CLIP.

A. Immunoblot (IB) analysis of Ago immunoprecipitates (IP) from P13 mouse
neocortex using pre‐immune IgG as a control or anti‐Ago monoclonal antibody
2A8 were blotted with 7G1‐1* antibody. B. Autoradiogram of 32P‐labeled RNA
crosslinked to mouse brain Ago purified by IP. RNA‐protein complexes of ~110
kD and ~ 130 kD are seen with 2A8 but not control IP.

C. PCR products

amplified after linker (36 nt) ligation to RNA products excised from B. Products
from the 110 kD RNA‐protein complex were ~22 nt miRNAs, and those from 130
kD complexes were predominantly mRNAs. D. Illustration showing proposed
interpretation of data in C. Ago (drawn based on structure 3F73 in PDB) (Wang
et al., 2008a) binds in a ternary complex to both miRNA and mRNA, with
sufficiently close contacts to allow UV‐crosslinking to either RNA; mRNA tags
will be in the immediate vicinity of miRNA binding sites. Putative crosslinking
sites are indicated as stars.
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Figure 4.3. Reproducibility of Ago‐miRNA CLIP results

A. Heat map comparing miRNAs by frequency with which they were detected
in Ago‐miRNA CLIP in five different experiments using two different antibodies.
The number of tags in each experiment was normalized by rank quantile
normalization and median value for each miRNA from 5 experiments is used as
normalized tag frequency to determine a final ranking. A heat map was
generated by the Treeview program (http://rana.lbl.gov/EisenSoftware.htm) with
log2 ratio of normalized tag frequency to median. Red tags are ranked above
median, green below, white at the median, grey is missing (no tags). % is the
number of tags in total tags from 5 experiments. B. Correlation of Ago‐miRNA
CLIP results using different antibodies. C. The top 30 miRNAs are shown for
each of 5 experiments. D. The bottom 30 miRNAs are shown.
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Figure 4.4. Comparison of Ago‐miRNA CLIP data with published profiles of
brain expressed miRNAs.

Generally the Ago‐miRNA CLIP set of miRNAs corresponded to previously
reported results, although there was a higher correlation between biologic
replicates in our experiments than with previously published measures of
miRNA frequency in brain, measured by cloning frequency12 (A,B,C) or bead‐
based cytometry13 (D,E,F) (R2 = 0.2 ‐ 0.32, higher than Ago‐miRNA CLIP in
brain vs miRNA frequency in liver (0.06‐0.12)). These differences might relate to
different developmental ages of brain used for isolation; Landgraf et al analyzed
P0 mouse brain, while Lu et al analyzed human brain. In addition, regulation of
Ago interaction with miRNA could account for differences between crosslinked
populations and whole miRNA populations, as the previously reported
approaches used whole small RNA populations for analysis. It is also notable
that a significant number of miRNAs identified by Ago HITS‐CLIP were not
found database derived from direct sequencing ((b); 350 miRNAs present in P13
brain Ago HITS‐CLIP that were absent from whole sequencing of miRNAs in P0
brain), suggesting the possibility that this method has greater sensitivity than
reported approaches.
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Figure 4.4 continues
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Figure 4.5. in silico random CLIP normalization.

A.Schematic of the in silico random CLIP normalization process and an example
are shown. For example, thresholds for gene A were estimated by in silico
random CLIP, and this estimate gives a normalization threshold of 3 (to yield an
acceptable P value, < 0.01). Hence in the cartoon on bottom left, clusters of peak
height < 3 were removed after normalization.
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Figure 4.6. Biologic complexity normalization.

Biologic complexity (BC) refers to overlapping tags between experiments. BC is
determined by taking data from each Brain HITS‐CLIP, normalizing by in silico
random CLIP for mRNA abundance, and comparing data from at least one of
each antibody immunoprecipitiation (2A8 and 7G1‐1*).

For example, for a

cluster to have a biologic complexity of 2, it must have at least one tag from 2A8
and 7G1‐1 Ago HITS‐CLIP experiments. For Brain E, since the animal used was
an FMRP KO, to be conservative, we only selected tags that were also present in
WT (Brain D), to avoid confounding data that might result from the absence of
FMRP.
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Figure 4.7.

Biologic complexity and peak height analysis of Ago mRNA

clusters.

A. Table of Ago mRNA clusters sorted by biologic complexity and number of
tags in the cluster peak (Peak height).

B.

Table of Ago clusters in genes

transcribed in P13 brain, as determined by Affymetrix exon array. C. Plot of
data in (A), demonstrating that data for samples with different biologic
complexity converge at clusters with peak height > 20, suggesting that stringent
data analysis can be obtained with peak height > 20.

D.

Comparison of

distribution of clusters depending on peak height in in silico random CLIP vs.
Ago‐mRNA CLIP, plotted with different biologic complexity. This allows P
values to be determined for selecting further stringent sets of clusters in a given
global threshold (peak height) although those clusters were already normalized
by in silico random CLIP.
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Figure 4.8. Simulations estimating the relationship between depth of HITS‐
CLIP sequencing and number of clusters/tags identified.

A. To estimate whether our sequencing depth was sufficiently saturated to give
a global view of Ago HITS‐CLIP targets, we undertook a simulation to see the
effects of the last 10% of sequencing on our final Ago ternary cluster map. 10% of
sequenced tags were removed randomly from each of 5 different AGO mRNA
CLIP results, then those tags were processed by in silico normalization,
alignment of tags using BLAT and cubic spline interpolation analysis. We then
performed the simulation 10 times and compared the number of Ago ternary
clusters (BC>=2) between the original set and the simulated one, focusing on the
top 20 miRNAs clusters which we used for the Ago maps. The recovery rate of
these simulation was ~92% for the Ago top 20 miRNA clusters (14411/15665) and
~95% for miR‐124 (1487/1561), which are higher than the expected rate (90%).
This increase of recovery rate was statistically significant (top 20; 1.02 = 92/90,
P=2.08 x 10‐11 and for miR‐124; 1.06 = 95/90, P=2.55 x 10‐7; Chi square test).
B. The simulation in (A) was repeated as a function of tags in the simulation.
This was accomplished by repeating the simulation removing a range of tags,
from 10‐90%. We estimated the recovery of Ago miR‐124 clusters (blue) and all
top 20 Ago‐miRNA‐mRNA clusters as indicated. These results indicate that our
sequencing depth is near the saturation point and is sufficient to show global
view of miRNA target sites for the top 20 miRNAs. For example, even after
removing 50% of tags, we had 88% recovery of the miR‐124 clusters.
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Figure 4.9. Reproducibility of Ago‐mRNA CLIP results

A. To define reproducibility of Ago‐mRNA clusters, we first identified inter‐
animal clusters10 with at least one tag in each of three biologic replicates.
Pearson correlation coefficients represent the correlation between the normalized
density of tags (log2 value after in silico random CLIP normalization) in each
cluster. B. The analysis in (A) was repeated, comparing reproducibility with the
two different Ago monoclonal antibodies. C. A genome‐wide graph of data
from (B).
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Figure 4.10. Analysis of Ago HITS‐CLIP tags and clusters

A‐B. Reproducibility of all Ago‐miRNA tags (A; graphed as log2(normalized
miRNA frequency) per brain) or all tags within Ago‐mRNA clusters. C. Location
of reproducible Ago‐mRNA tags (tags in clusters; BC>2) in the genome.
Annotations are from RefSeq;”others” are unannotated EST transcripts, non‐
coding RNAs are from lincRNAs50 or FANTOM3. D. Top panel: The position of
robust Ago‐mRNA clusters (BC = 5) in transcripts is plotted relative to the stop
codon and 3’ end (presumptive poly(A) site, as indicated). Data is plotted as
normalized density relative to transcript abundance for Ago‐mRNA clusters
(blue) or control clusters (red), (standard deviations are shown in light colors).
Regions with significant enrichment relative to control are indicated with black
bars (> 3 standard deviations; P<0.003). Cluster enrichment ~1kb downstream
from stop codon appears to be due to a large number of transcripts with ~1kb 3’
UTRs (data not shown). Bottom panel: All individual clusters (BC=5) are shown
(each is a different color).
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Figure 4.11. Ago mRNA crosslinking sites within transcribed genes.

A. Ago mRNA CLIP tags and clusters according to their position in transcribed
genes. The region of transcript (5’ UTR, coding sequence (CDS), or 3’ UTR) was
determined by RefSeq annotation for all brain expressed transcripts (P13 mouse).
The number of clusters refers to all clusters with BC > 2, and the number of tags
refers to the number of tags within the cluster.

Total length refers to the

aggregate length of all transcribed brain sequences for each given transcribed
region. Observed/Expected refers to the ratio of number of clusters or tags per
expected number based on total length. P value was calculated by Chi square.
Ago mRNA crosslinking sites in 3’UTR are ~1.5 fold enriched comparing to the
expected number. B. The percentage of clusters in different regions of transcripts
is shown according to their Rank (cluster height, defined as the maximum
number of tags in each cluster). All clusters were analyzed, but only the top
ranking 100 are shown. C. As in (B), with clusters BC = 5.
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Table 4.1. High‐throughput sequencing results from Ago HITS‐CLIP.

Over 80% of RNAs isolated and sequenced from the upper 130 kD RNA‐protein
crosslinked band correspond to genomic sequences, and between 72 and 88% of
RNAs from the lower 110 kD RNA‐protein band correspond to miRNAs. Raw
tags refer to number of Illumina tags after filtering step which company
provided; BLAT refers to number of tags that could be aligned with genomic
sequences from mm8, and BLAST from miRBASE, % is number of matched tags
from BLAT search, using parameters (> 90% identity, Tag start <=3) or BLAST
search result, filtered to include only matches with more than 95% identity.
Unique tags are tags with different 5’ ends after discarding those with identical
genomic location

miRBASE from May 2008 was used, which included 579

known mouse miRNAs (including passenger strand).
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Table 4.2. Verification of exon array usage for in silico random CLIP
normalization.

To estimate the effect of varying (N) on the outcome of in silico CLIP,
simulations were done with the gene Chad7 that has the minimum abundance
used in our experiments and in in silico CLIP. The top table shows that Tn does
not change as a function of abundance (Nn). The first column values indicate
that the array value of every transcript was increased together with Chad7. All
simulation has the same final result which selects Ago CLIP clusters of which
height is more than 2. The middle table shows the maximum cluster heights
over 500 simulations.

No clusters are greater than 2 (Mn).

The final FDR

calculation based on the results of the middle table (e.g. 12/500=0.024) shows that
for a cluster height of 3, the FDR does not change, with each FDR < 0.01. In
conclusion, this simulation explains that the results are not affected by (N).
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CHAPTER V. DECODING OF MIRNA‐MRNA
INTERACTION MAPS

Introduction
MicroRNAs (miRNAs) are short (18‐26 nt) sequences that act as post‐
transcriptional repressors of gene expression. 721 miRNAs have been reported
in the human genome (miRBase release 14; 579 in mouse genome) and each is
believed to bind directly to many mRNAs to regulate their translation or stability.
Thus, miRNAs represent a key regulatory mechanism affecting numerous
cellular activities, and are of particular interest in research about disease such as
cancer (Kim et al., 2009b)

Despite the biologic importance of miRNAs, it has not been possible to make a
general determination about the specific RNA targets upon which they act. The
difficulty stems from the discovery that functional miRNA‐mRNA interactions
may require as few as 6 nucleotides (nt) of consecutive complementary seed
sequences (Lim et al., 2005). Since such interactions are present on average every
~4 kb, it is possible that miRNAs bind to a very broad range of mRNAs, but the
extent of their regulatory potential is not known. Bioinformatic analysis has
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greatly improved the ability to recognize bona fide miRNA binding sites (Krek et
al., 2005; Lewis et al., 2005; Rajewsky, 2006), principally by constraining searches
for evolutionary conservation in 3’ UTR seed sequences. However, different
algorithms still produce significantly divergent results, with significant false‐
positive rates (Bentwich, 2005).

In addition, many miRNAs are encoded at

multiple gene loci or are present in closely related miRNA families, complicating
interpretation of loss of function studies in mammals (Ebert et al., 2007; Schaefer
et al., 2007; Ventura, 2008; Xiao et al., 2007), although such studies have been
informative for some miRNAs, particularly in invertebrates (Ambros, 2004;
Johnston and Hobert, 2003b).

Low sequence complexity and functional

redundancy have complicated efforts at large‐scale validation of individual
miRNA‐mRNA interaction sites in vivo. miRNA overexpression or knockdown
studies, most recently in combination with proteomic studies (Baek et al., 2008;
Selbach et al., 2008), have led to the conclusion that individual miRNAs generally
regulate a relatively small number of proteins at modest levels (< 2‐fold),
although the false‐positive rate of target predictions remains high (~up to 66%)
(Baek et al., 2008), and the data sets analysed have been of limited size (~5,000
proteins). Similar high false‐positive rates have been observed when miRNAs
were co‐immunoprecipitated with Ago proteins (Beitzinger et al., 2007; Easow et
al., 2007; Hammell, 2008; Hendrickson et al., 2008; Zhang, 2007). A critical caveat
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common to all of these studies is their inability to definitively distinguish direct
from indirect miRNA‐target interactions.

At the same time, as therapeutic

antisense strategies become more viable (van Rooij et al., 2008a; van Rooij et al.,
2008b; Wheeler et al., 2007), knowledge of direct miRNA target sites has become
increasingly important.

We used HITS‐CLIP to covalently crosslink native Argonaute (Ago) protein‐
RNA complexes in mouse brain. This produced two simultaneous datasets—
Ago‐miRNA and Ago‐mRNA binding sites. Here, these two Ago CLIP data
were combined and decoded by bioinformatic analysis to identify miRNA‐target
mRNA interaction sites. We validated genome‐wide interaction maps for miR‐
124, and generated additional maps for the 20 most abundant miRNAs present in
P13 mouse brain. Ago HITS‐CLIP provides a general platform for exploring the
specificity and range of miRNA action in vivo, and identifies precise sequences
for targeting clinically relevant miRNA‐mRNA interactions.
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Results
Decoding miRNA‐mRNA interactions from Ago HITS‐CLIP data
As a first estimate of whether a relationship between Ago‐mRNA clusters and
sites of miRNA action exists, we performed an unbiased search for all 6‐8
nucleotides (nt) sequence motifs within the entire length of Ago‐mRNA clusters,
using linear regression analysis (Foat et al., 2005). The six most enriched motifs
corresponded to seed sequences from the miRNAs most frequently crosslinked
in Ago‐miRNA CLIP (Table 5.1), with the most significant match corresponding
to miR‐124, a brain‐specific miRNA (P = 8.3 x 10‐58; this was not the same as the
most frequently crosslinked Ago‐miRNA (miR‐30), perhaps reflecting over‐
representation of miR‐124 seed sequences in the genome or contributions from
rules of Ago binding that are not apparent). To more precisely define Ago‐
mRNA clusters, we analyzed 61 robust Ago‐mRNA clusters (BC = 5; total tags >
30) using cubic spline interpolation analysis. We found that Ago bound within
45‐60 nt of the cluster peaks 95% of the time (defined by analysis of overlapping
Ago‐mRNA tags, or by a minimum region common to all 61 clusters, tan and
green graphs, respectively, Figure 5.1A), and we define this region as the Ago‐
mRNA footprint region. Linear regression again demonstrated a high correlation
between the frequency of Ago‐miRNAs and the frequency of their seed
sequences in this Ago‐mRNA footprint region (Figure 5.1B and Table 5.2).
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We next examined the position and frequency of conserved seed sequences
present in the top 30 miRNAs identified within the Ago‐mRNA footprint. 171
seed sites were identified within 100 nt of 134 robust Ago‐mRNA clusters, the
majority of which (118) were located within the predicted 60 nt Ago‐mRNA
footprint (Figure 5.2A). The distribution of seed sequences appears to follow a
leptokurtic distribution (one in which the peak is higher and sharper than a
normal distribution; excess kurtosis (k) = 1.08, versus 0 in a normal distribution),
illustrating the high resolution of CLIP to determine Ago‐RNA interactions. As a
control, seed sequences of a “negative” group of miRNAs (the lowest ranking
miRNAs from the Ago‐miRNA CLIP list) were uniformly distributed in these
clusters (Figure 5.2A; k = ‐1.35, versus ‐1.2 in uniform distribution).

Taken

together, these results indicate that the Ago‐mRNA footprint is rich in and may
predict miRNA binding sites with enhanced specificity

Ago HITS‐CLIP and miR‐124
To further explore the relationship between the Ago footprint and miRNA
binding we focused on miR‐124 sites, a well studied brain‐specific miRNA. We
found a marked enrichment of conserved miR‐124 seed sequences in Ago‐mRNA
clusters (Figure 5.2B). 86% of the predicted miR‐124 binding sites were present
within the Ago footprint region, again in a tight peak region showing leptokurtic
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distribution (Figure 5.2B; k = 11.63).

These results were more sensitive and

sufficiently specific, relative to more stringent analyses (Figure 5.2A), such that
we chose this threshold (BC > 2) for subsequent analyses. While some predicted
seeds outside of the Ago footprint might correspond to false positives, we also
noted small secondary peaks at ~ +/‐ 50 nt outside the Ago footprint, suggesting
the possibility of cooperative secondary miR‐124 binding sites in some
transcripts, consistent with data suggesting miRNA cooperativity may occur
within this range of distance (Grimson, 2007).

We searched published examples of miR‐124 regulated transcripts for Ago‐
mRNA clusters with miR‐124 seeds within the predicted 62 nt Ago footprint
(termed Ago‐miR‐124 ternary clusters). We identified such ternary clusters 5 of 5
transcripts in which miR‐124 seed sites had been well defined by functional
studies (including mutagenesis of seed sequences in full length 3’UTR; Figure
5.3). In each transcript, there were many predicted miRNA target sites in the 3’
UTR, but only a small number of Ago‐mRNA ternary clusters found, suggesting
that there may be a significant number of false positive predictions from
bioinformatic algorithms (Figure 5.3). For example the 3’ UTR of Itgb1 mRNA
has ~50 predicted miRNA target sites, including two miR‐124 sites, but only 5
Ago‐mRNA ternary clusters (Figure. 5.3A). Using the Ago footprint to predict
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miRNAs bound at these sites, we identified three as miR‐124 sites, one of which
was missed by computational predictions because the seed sequence is not well
conserved across species (Figure. 5.3A); similar observations were made in the
Ctdsp1 3’ UTR (Figure. 5.3C). Previous luciferase assays demonstrated that miR‐
124 suppression of Itgb1 (to 35% control levels) was partially reversed (to 85%
control levels) by mutating both of the two predicted seed sequences (Yu et al.,
2008); our observation of an Ago‐miR‐124 ternary cluster at this third non‐
conserved site may explain the partial rescue. Conversely, in the Polypyrimidine
tract‐binding protein 1 (Ptbp1) 3’ UTR, the absence of any Ago footprint at a
predicted miR‐9 seed site was consistent with prior studies which found this site
to be non‐functional (Makeyev et al., 2007)(Figure 5.3B). Additionally, Ptbp1 has
seven predicted miR‐124 seed sites, of which five were previously tested and
only 2 found to be functional in luciferase assays (Makeyev et al., 2007); only
these 2 sites harbored Ago‐miR‐124 ternary clusters (Figure 5.3B).

Validating Ago HITS‐CLIP for miR‐124
To extend these observations, we compiled brain‐expressed transcripts from a
meta‐analysis of five published microarray experiments (Table 5.4), which
sought to identify transcripts that were significantly downregulated by miR‐124
overexpression in HeLa and other cell lines (Baek et al., 2008; Hendrickson et al.,
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2008; Lim et al., 2005; Makeyev et al., 2007; Wang, 2006). Transcripts with
predicted miR‐124 seeds showed miR‐124 dependent mRNA and protein
suppression (Figure 5.5A‐B), consistent with previous observations (Baek et al.,
2008; Selbach et al., 2008). Remarkably, transcripts with Ago‐miR‐124 ternary
clusters had a significant tendency to be downregulated at the RNA and protein
level (P<0.01, relative to mir‐124 seed prediction, Kolmogorov‐Smirnov test,
Figure 5.5A‐B). We validated these studies experimentally by examining Ago‐
mRNA clusters that appeared de novo in HeLa cells (which do not express
endogenous miR‐124) after miR‐124 transfection (Figure 5.4). Applying this data
to the meta‐analysis, mRNAs whose 3’ UTRs harbored new Ago‐miR‐124 ternary
clusters after miR‐124 transfection showed an even greater enrichment in miR‐
124‐dependent changes in transcript (Figure 5.5C) and protein (Figure 5.5D)
levels (P<0.01, Kolmogorov‐Smirnov test).

We next examined Ago‐miR‐124 ternary clusters present in validated individual
transcripts identified from among 168 candidate miR‐124 regulated transcripts
(Table 5.3) (Lim et al., 2005). These targets had been further analyzed by Hannon
and colleagues (Karginov et al., 2007) using a rigorous 3‐part strategy to
experimentally validate 22 of them (although miR‐124 binding sites were not
generally defined). We found that 16 of these 22 harbored Ago‐miR‐124 ternary
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clusters in the 3’ UTR (Table 5.3). In 5 additional transcripts with low expression
levels, Ago‐mRNA CLIP‐tags could be identified at predicted miR‐124 seed sites.
For transcripts of even moderate abundance (>700; average for P13 brain
transcripts ~1,255), we identified all 10/10 predicted targets (Table 1). These data
indicate that the sensitivity and specificity of detecting bona fide miR‐124 targets
is markedly enhanced by identification of Ago‐miR‐124 ternary clusters. We also
examined this set of 22 targets (Karginov et al., 2007) for de novo Ago‐mRNA
clusters present in the 3’ UTR after miR‐124 transfection (Table 5.3). Remarkably,
from among many potential miR‐124 seed sites, 17 de novo Ago‐miR‐124 ternary
clusters appeared after transfection and 14 of 17 were at precisely the positions
predicted from brain Ago miR‐124 maps. Genome‐wide, we identified 204 de
novo Ago–miR‐124 clusters with conserved seeds in mouse brain transcripts; of
these 98 were independently identified as mouse brain Ago–miR‐124
ternaryclusters. Taken together, these data demonstrate the Ago HITS‐CLIP map
predicts experimentally induced and functional sites of miRNA regulation that
are not evident through bioinformatic analysis alone.

Predicting miRNA functional networks
Based on the robust correlation between previously validated miR‐124 functional
sites and Ago HITS‐CLIP, we examined Ago‐mRNA clusters to predict binding
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maps for the 20 most abundant miRNAs identified in Ago‐miRNA CLIP. These
maps (Figure 5.7A) show Ago binds to target transcripts at very specific sites: on
average there are only 2.6 Ago‐mRNA clusters (BC > 2) per transcript (2.12 per 3’
UTR) and each miRNA binds an average of only 655 targets (Figure 5.6). To
explore the potential of Ago HITS‐CLIP maps to define miRNA regulated
transcripts, we examined the functions encoded by the predicted targets of these
20 miRNAs using gene ontology analysis; comparison of these results with
predictions made using GO analysis of TargetScan predictions (Figure 5.8)
demonstrates that the FDR rate and ‘quality’ of the protein network deteriorate
substantially when the Ago‐mRNA map is not used (Figure 5.10).

Target

predictions from the Ago HITS‐CLIP map suggest that diverse neuronal
functions are regulated by different sets of miRNAs (Figure 5.7B). The largest set
of miRNA associated functions, “neuronal differentiation” illustrates interwoven
but distinct pathways predicted to be regulated by three miRNAs expressed in
neurons (Figure. 5.7C). The Ago‐RNA ternary map corresponds remarkably well
with the current view of miR‐124, miR‐125 (Wu and Belasco, 2005) and miR‐9
function, including actions to promote neurite outgrowth and differentiation by
inhibiting Ago‐miR‐124 targets (Figure 5.7C) such as Itgb1 (Yu et al., 2008)
(Figure 5.3A), Iqgap1 (Lim et al., 2005) (Figure 5.3E), Ptbp1 (Makeyev et al., 2007)
(Figure 5.3B), and Sox9 (Cheng et al., 2009) (Figure 5.3F) and Ago‐miR‐9 targets
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such as Fgfr1 (Leucht et al., 2008) (Figure 5.3G) and Foxg1 (Shibata et al., 2008)
(Figure 5.3H).

Discussion
Ago‐miRNA‐mRNA ternary maps identify functionally relevant miRNA binding
sites in living tissues, and were developed in the context of several recent studies.
Crystallographic structures of Ago miRNA‐mRNA ternary complexes (Wang et
al., 2008a) demonstrated close contacts between all three molecules, consistent
with the ability of CLIP (Ule et al., 2003), which requires close protein‐RNA
contacts to detect both Ago miRNA and mRNA interactions. The development
of HITS‐CLIP set the stage for generating and analyzing genome‐wide RNA‐
protein maps in the brain (Licatalosi et al., 2008) and cultured cells (Yeo, 2009).
High throughput experiments and bioinformatic analysis together generated
genome‐wide predictions of miRNA seed sequences, particularly of miR‐124.
These studies demonstrated that miR‐124 simultaneously represses hundreds of
transcripts (Baek et al., 2008; Hendrickson et al., 2008; Lim et al., 2005; Makeyev
et al., 2007; Wang, 2006). and provided a genome‐wide “gold standard” with
which to compare Ago HITS‐CLIP data.
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Ago HITS‐CLIP resolves some roadblocks that have arisen in efforts to
understand miRNA action.

It has been difficult to discriminate direct from

indirect actions of miRNAs, and to extrapolate miRNA overexpression studies in
tissue culture to organismal miRNA action. Target RNAs have previously been
identified by immunoprecipitation, microarray analysis (Karginov et al., 2007)
(Hendrickson et al., 2008) and reporter validation assays, with the concern that
low stringency immunoprecipitation of non‐crosslinked RNA‐protein complexes,
including Ago‐miRNAs (Mili and Steitz, 2004), may purify indirect targets. This
has spurred interest in efforts to explore miRNA‐target identification by
covalently crosslinking, using formaldehyde or 4‐thio‐uridine modified RNA in
culture to identify transcripts complexed with Ago, miRNAs and additional
proteins (Kirino and Mourelatos, 2008) (Vasudevan et al., 2007).

HITS‐CLIP

offers a clear means of identifying direct Ago targets and identifying specific
interaction sites, which in turn offers the possibility of specifically targeting
miRNA activity.

Ago‐HITS‐CLIP complements bioinformatic approaches to miRNA target
identification by restricting the sequence space to be analyzed to the ~45‐60 nt
Ago footprint. For highly conserved 3’ UTRs, such as those of the RNABPs
Ptbp2, Nova1, and Fmr1, many miRNA sites are predicted using algorithms that
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rely on sequence conservation, but each has only one Ago‐mRNA CLIP cluster
(Figure 5.9). In fact, miRNA selectivity is very high (Figure 5.3 and 5.9) such that
on average transcripts have between 1‐3 major Ago binding sites in a single
tissue (Figure 5.6). Ago‐mRNA binding sites themselves have no apparent
sequence preference, suggesting that accessibility may rely on additional
RNABPs. Such a mechanism, which may be assessed by overlaying HITS‐CLIP
maps of different RNABPs (Licatalosi et al., 2008), could provide a means of
dynamically regulating miRNA binding and regulation.

By simultaneously generating binding maps for multiple miRNAs, Ago HITS‐
CLIP offers a new approach to understanding combinatorial control of target
RNA expression. Both the FDR rate and evidence for such miRNA target protein
networks deteriorate substantially when predicted maps are generated without
experimental Ago HITS‐CLIP data (Figure 5.10). At the same time, analysis of a
single miRNA, miR‐124, demonstrated that its expression not only induced Ago
to bind miR‐124 sites, but reduced or precluded Ago binding to sites occupied in
untransfected cells (Table 5.3), perhaps reflecting competition between a limited
capacity for miRNA binding on a given 3’ UTR.

Such Ago occlusion has

important mechanistic, experimental and clinical implications, where studies
manipulating miRNA levels are envisioned.
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Contributions
All bioinformatic analysis, transfection of miRNA mimics and Ago CLIP
experiments were done by Sung Wook Chi under the supervision of Robert B.
Darnell. Aldo Mele helped with HITS‐CLIP experiments. Scott Dewell helped
with high‐throughput sequencing (Illumina Genome Analyser).
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Figure 5.1. Distribution of mRNA tags
(a) Ago‐mRNA cluster width and peaks. The peaks of 61 robust clusters (BC = 5,
peak height >30, with single peaks) were determined, and the position of tags
(brown lines and fraction plotted as brown graph) and width of individual
clusters (green lines and fraction plotted as green graph) are shown relative to
the peaks. The minimum region of overlap of all clusters (100%) was within ‐24
and +22 nt of cluster peaks, and > 95% were within ‐30 and +32 nt, suggesting
that the Ago footprint on mRNA spans 62 nt (or, more stringently, 46 nt). (b) A
linear regression model was used to compare miRNA seed matches enriched in
the stringent Ago footprint region with the frequency of miRNAs experimentally
determined by Ago‐miRNA HITS‐CLIP. For each miRNA in the database, 3
different six‐mers (corresponding to positions 1‐8) were compared with
sequences in Ago‐mRNA cluster peaks (‐24 to +22) and analyzed by linear
regression model according to the peak height. 22 values with P < 0.05 were
selected.
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Figure 5.1
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Figure 5.2.

Distribution of mRNA tags correlates with seed sequences of

miRNAs from Ago CLIP.

A. The position of conserved core seed matches (position 2‐7) from the top 30
Ago‐bound miRNAs (independent of peak height; purple colors, including miR‐
124, red; or, bottom 30 miRNAs, expressed at extremely low levels in brain; black
to gray colors) are plotted relative to the peak of 134 robust clusters (BC = 5, peak
height >30). 118 of 171 seed matches are within the Ago 62 nt footprint B. The
position of conserved miR‐124 seed matches (bottom panel; each is represented
by a different color) were plotted relative to the peak position of all Ago‐mRNA
clusters (BC > 2). Top panel; distribution of mir‐124 seed matches (plotted
relative to cluster peak, normalized to number of clusters; red graph); pale color
indicates standard deviation. Excess kurtosis (k), a measure of the ʺpeakednessʺ
of the probability distribution of a real‐valued random variable, indicates that
seed sites are present in a sharp peak relative to a normal distribution.
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Figure 5.2
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Figure 5.3. Ago‐miRNA ternary clusters in validated miR‐124 mRNA targets.

A. Ago–mRNA CLIP tags (top panel: raw tags, one color per biologic replicate:
second panel: ternary map of Ago‐mRNA normalized clusters around top
predicted miRNA sites) compared with predicted miRNA sites (using indicated
algorithms) for the 3’ UTR of Itgb1 (third panel; colors indicate predicted top 20
miRNAs as in Fig. 5; grey bars indicate miRNAs ranking below the top 20 (per
heat‐map) in Ago‐miRNA CLIP).

All predicted miR‐124 6‐8 mer seeds

(conserved (red) or non‐conserved (yellow) sites) are shown.

Bottom panel

shows data from luciferase assays in which mutagenesis of predicted miR‐124
seeds at the indicated positions had the indicated effects on restoring from miR‐
124 mediated suppression (35% of baseline luciferase levels). B. Ago‐miRNA
ternary maps compared with previously reported functional data for Ptbp1. C.
Ago ternary map of Ctdsp1. D. Ago ternary map of Vamp3. E‐F.I. Iqgap1 and
Sox9 are previously identified as miR‐124 targets. The fragments used for
luciferase assay are shown with black bars. The Ago ternary map identified
exact sites of validated miRNA binding within the fragments as shown. G‐H.
Validated miR‐9 targets, Fgfr1 and FoxG1 are shown. Fgfr1 is validated as miR‐9
target in Zebrafish.
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Figure 5.3
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Figure 5.3 continues
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Figure 5.3 continues
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Figure 5.4. Argonaute HITS‐CLIP in HeLa cells transfected with control or
miR‐124 microRNAs.

Argonaute HITS‐CLIP in HeLa cells transfected with control or miR‐124
microRNAs. A. 32P‐labeled RNA crosslinked to Ago immunoprecipiated with
7G1‐1* from miR‐124 or control miRNA transfected HeLa cells are shown. Two
Ago RNA cross‐linked complexes (~130kD for Ago‐mRNA and ~110kD for Ago‐
miRNA) are specific in UV‐irradiated tissue (+XL) compared to non‐irradiated
brain (–XL). B. The same result as A in a CLIP experiment using 2A8.

Also

shown is a comparison of overdigestion of Ago RNA cross‐linked complex (1:100
RNase A). C. HITS‐CLIP sequencing results of RNAs isolated from the 130 kD
RNA‐protein complex in 8 HeLa experiments with two different miRNA
transfections (miR‐124 and control miRNA) and two different antibodies (2A8
and 7G1‐1). Raw tags (prefiltered) refer to number of Illumina tags prior to
default filtering; aligned tags refers to number of tags that could be aligned with
genomic sequences from human genome database (hg18), derived from the
combination of two alignment results using BLAT and ELAND (Efficient Large‐
Scale Alignment of Nucleotide Databases; provided by Illumina) program with
same criteria used in AGO‐CLIP in mouse brain (> 90% identity, Tag start <=3).
Unique tags are tags with different 5’ ends or different degenerative 4 nucleotide
barcode introduced in 5ʹ fusion linker.
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Figure 5.4
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Figure 5.5. Meta‐analysis of Ago‐mRNA clusters in large‐scale screens of miR‐
124 regulated targets.

A.

Transcripts with predicted (conserved) miR‐124 seeds (purple line)

showed miR‐124 suppression relative to all transcripts expressed in brain and
cell lines (blue line) or those with no miR‐124 seed sequences (green line).
Transcripts with Ago‐miR‐124 ternary clusters (containing both miR‐124 seed
sequences and Ago‐mRNA CLIP tags; red line) showed further miR‐124
suppression. B. Similar results were seen when analyzing miR‐124 dependent
protein suppression (identified by SILAC), with discrimination by the presence
of Ago‐miR‐124 ternary clusters especially evident where there were smaller
numbers of transcripts showing larger changes (log2<‐0.4; inset). C. Transcripts
expressed in miR‐124 transfected HeLa cells that harbor new Ago‐miR‐124
clusters (red line; or a subset of transcripts also harboring Ago‐miR‐124 clusters
in mouse brain; yellow line), compared with previous analysis7 of regulated
transcripts in miR‐124 transfected HeLa cells. D. As in C, plotted for predicted
protein levels, compared with prior data.
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Figure 5.5
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Figure 5.6. AGO miRNA ternary map.

A. Table representing number of transcripts with given number of Ago‐mRNA
clusters (BC > 2) in 3’UTR, which shows average ~2 clusters per transcript in
3’UTR. The average number of clusters/transcript, Ago‐regulated transcript, or 3’
UTR of Ago‐regulated transcripts are shown. B. Number of transcripts predicted
as each top 20 Ago‐miRNA targets (collapsed by family; see “pink” lines in
Supplementary Table 3), based on Ago miRNA ternary map. C. Ago miRNA
ternary map of top 20 Ago‐miRNAs in mouse genome.
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Figure 5.6
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Figure 5.7. Analysis of Ago‐miRNA ternary maps.

(a)

Genome‐wide views of Ago‐miRNA ternary maps for the top 20 miRNAs

from Ago HITS‐CLIP (colors represent individual miRNA targets as indicated in
(b)) are shown for the Itgb1 gene (top panel), the local gene region (middle panel;
all transcripts are expressed in P13 brain except those outlined in grey boxes),
showing tags in neighboring 3’ UTRs, and for all of chromosome 8 (bottom
panel). (b) Heat map derived from gene ontology (GO) analysis of transcripts
identified as targets of each of the top 20 miRNAs. Tree shows the hierarchical
clustering of miRNAs based on GO. Significant clusters are outlined with black
boxes.

(c) Ago HITS‐CLIP targets are shown for the significant pathways

(neuronal differentiation/cytoskeleton regulation; based on FDR; for miR‐124,
miR‐9 and miR‐125 in mouse brain. Actin cytoskeleton pathways are shown
based on KEGG database (http://www.genome.jp/kegg/).
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Figure 5.7
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Figure 5.8. Gene ontology analysis of AGO ternary map.

This figure shows that target transcripts for each of the Ago top 20 miRNA
ternary complexes that were used for gene ontology analysis. A. For each
category, enrichment was compared with all P13 brain expressed transcripts
using GoMiner (http://discover.nci.nih.gov/gominer/). False discovery rate (FDR)
was calculated for each GO category and is represented as a different color as
indicated. Hierarchical clustering of miRNAs and GO categories was performed
using Cluster program and visualized as heat map and tree by Treeview
(http://rana.lbl.gov/EisenSoftware.htm). GO categories were divided into two
groups, one with little or no miRNA enrichment, and a second with a large
amount of miRNA enrichment. The second group is shown here. B. As in (A),
but using targets identified by TargetScan 4.1 rather than Ago HITS‐CLIP, are
shown for comparison. C‐D. GO analysis using DAVID
(http://david.abcc.ncifcrf.gov/) illustrating different results of the predicted actin
cytoskeleton miRNA regulatory map for miR‐124, miR‐9 and miR‐125 that are
obtained with Ago HITS‐CLIP and TargetScan 4.1. Taken together, these figures
illustrate that both the FDR rate and evidence for a protein network deteriorate
substantially when Ago‐mRNA tags are not used.
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Figure 5.8
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Figure 5.9. Ago miRNA ternary map in miRNA targets.

This figure shows the same analysis as in Figure 3 on five of additional 3’ UTRs.
A‐C. Although many miRNA binding sites are predicted in those neuronal
genes due to high conservation in 3’UTR, only one Ago‐miRNA ternary cluster
was identified in each transcript by AGO‐HITS‐CLIP in P13 mouse brain
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Figure 5.9
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Figure 5.10. Gene ontology and pathway analysis of AGO mRNA ternary map

GO analysis using DAVID (http://david.abcc.ncifcrf.gov/) illustrating different results of
the predicted actin cytoskeleton miRNA regulatory map for miR-124, miR-9 and miR125 that are obtained with Ago HITS-CLIP (A) and TargetScan 4.1 (B). Taken together,
these figures illustrate that both the FDR rate and evidence for a protein network
deteriorate substantially when Ago-mRNA tags are not used.
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Figure 5.10
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Table 5.1. Correlation of Ago‐miRNA and Ago‐mRNA CLIP data

A. We correlated all possible 6 to 8‐mer motifs present in Ago‐mRNA clusters
(BC > 2) with cluster height (log2(maximum tag number) per cluster), using the
MatrixREDUCE

linear

regression

model:

( http://bussemaker.bio.columbia.edu/software/MatrixREDUCE/11). The most
enriched motifs selected by default parameters (except –max_gap=0) are shown.
B. Since some miRNAs were missing from the analysis in (A), we analyzed the
7mer seeds (position 2‐8) present in the top 10 miRNAs identified from Ago‐
miRNA CLIP. We compared with their observed (obs) versus expected (exp;
from P13 brain transcripts) frequency in Ago‐mRNA clusters (BC > 2). Seed
sequences from 8 of the top 10 Ago‐CLIP miRNAs were enriched in Ago‐mRNA
clusters. The miR124 seed match sequence is over‐represented in the mouse
genome and also in the mouse exons by about 50% (data not shown). This means
that there are more miR‐124 potential binding sites in the genome (we calculated
this as 1.33 fold (51,461 total 6‐mers for miR‐124, vs. 38,752 for miR‐30), and we
interpreted this correlation as being consistent with a relative increase in miR‐124
bound sites. It is also possible that there is underlying biologic regulation that
we do not understand, or that there are additional rules of binding that are not
apparent in current analyses.
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Table 5.1
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Table 5.2. Generalized correlation of Ago‐miRNA and Ago‐mRNA CLIP.

A. Analysis as in Supplementary Table 2, but correlating all possible 6 to 8‐mer
motifs present in a narrowly defined Ago‐mRNA footprint region (‐24 to + 22 nt
from peak, a region in which 100% of clusters are represented). All top ranking
motifs are seed sequences from top 8 ranked miRNAs in AGO‐miRNA CLIP B.
For each miRNA in the database, 3 different six‐mers (corresponding to positions
1‐8) were compared with sequences in Ago‐mRNA cluster peaks (‐24 to +22) and
analyzed by linear regression model according to the peak height. 22 values
with P < 0.05 were selected.

154

Table 5.2
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Table 5.3. Ago‐miR‐124 ternary maps in brain and transfected HeLa cells.

Left panel: Comparison of 22 validated miR‐124 targets44 with Ago‐miR‐124
ternary clusters in brain transcripts (BC > 2); miR‐124 clusters are shown
graphically above each 3’ UTR and corresponding conserved (red) or non‐
conserved (yellow) miR‐124 seeds below) were identified in 16 of 22 validated
transcripts (gene names colored red). In 5 additional transcripts (names colored
orange) clusters were below normalization threshold, but individual Ago‐mRNA
CLIP tags are shown. Tom1l1 had no detectable Ago binding, although notably a
brain‐expressed antisense transcript (Cox11) is present. Previously reported
changes in miR‐124 dependent transcript levels from miR‐124 transfected HeLa
cells7, and levels of the same transcript (“tx”) in mouse brain (normalized probe
intensities) are shown. Right panels: Columns represent Ago‐miR‐124 ternary
clusters in HeLa cells transfected with either miR‐124 or a control microRNA (“‐
miR‐124”). 17 de novo Ago‐miR‐124 ternary clusters (red; present only after
miR‐124 transfection) are shown, together with clusters present in both control
and miR‐124 transfected cells (purple), or present in control HeLa cells alone
(blue).
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Table 5.4. Meta‐analysis of five microarray studies in miR‐124 overexpression.

Five previous microarray experiments in miR‐124 tranfected cells used for meta
analysis.
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Table 5.4
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CHAPTER VI. ANALYSIS OF MIRNA‐MRNA
INTERACTIONS: BEYOND THE SEED

Introduction
miRNAs play critical roles in the regulation of gene expression. However, since
miRNAs preferentially base pair with only 6‐8 nucleotides of mRNA through
their seed region (position 1‐8), predicting target mRNAs is a major challenge
(Bartel, 2009). High‐throughput sequencing of RNAs isolated by crosslinking
immunoprecipitation (HITS‐CLIP) has identified functional protein‐RNA
interaction sites (Licatalosi et al., 2008). We used HITS‐CLIP to covalently
crosslink native Argonaute (Ago) protein‐RNA complexes in mouse brain,
generating two sets of biochemical results—Ago‐miRNA CLIP and Ago‐mRNA
CLIP. By generating this collection, we constrained the sequence space that
needed to be analyzed to predict the local regions of mRNAs to which Ago
crosslinked and the potential miRNAs bound there, substantially reducing the
rate of false‐positive predictions of miRNA binding.

Defining Ago‐mRNA interaction sites using HITS‐CLIP has the potential to
inform many different bioinformatic tools developed to predict miRNA target
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interactions. The main remaining problem is mining the information from Ago
interacting sites and developing bioinformatic methods to pair‐up miRNAs with
collected targets sites. In the previous work, we have chosen to focus on
validating our results by using seed‐driven approaches together with defining
Ago footprints of mRNA tags and decoded Ago ternary maps showing miRNA‐
mRNA interactions. However, we recognized that not all Ago binding need to be
constrained by seed rules. For example, 27% of Ago‐mRNA clusters (BC > 2)
have no predicted 6‐mer seed sites from among the top 20 Ago‐miRNAs families.
Such “orphan” Ago‐mRNA clusters could be bound by miRNAs through other
rules of binding.

Initially, seed‐driven approaches for miRNA target prediction were based on
evolutionary constraints (Lewis et al., 2005) and bioinformatic analysis (Xie et al.,
2005). Although the seed match rule was further supported by large‐scale
experiments (Baek et al., 2008; Lim et al., 2005; Selbach et al., 2008) and greatly
helped to characterize the miRNA targets and functions, there still is no evidence
that any miRNA seed must be contiguously base‐paired for a target site to be
functional. Several groups reported that miRNAs can allow interactions with
wobble (G:U pairing) or bulge in the seed region. In C. elegans, it was validated
by both in vivo and in vitro assays that lin‐41 has such wobble and bulge sites for
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let‐7 (Vella et al., 2004). In addition, GU wobbles in the seed region do not
prevent endogenous lsy‐6 from downregulating cog‐1 (Didiano and Hobert,
2006). More recently, a similar result was also shown in a mammal (Tay et al.,
2008); Four of the five target sites in the coding sequence (CDS) of Nanog, Oct4
and Sox2, which are shown to modulate ESC differentiation, contained wobble
and bulge sites in the seed.

Although such bulges and wobbles are reported to be functional (Didiano and
Hobert, 2006; Tay et al., 2008; Vella et al., 2004), rules based on these few reports
have not been developed to allow miRNA target predicitons. Since such
additional rules have the target sites predicted more often by chance, the
prediction results generate more false‐positives, which are more difficult to be
filtered‐out, than the seed based approaches. None of the atypical binding sites
have been over‐represented in the data from the large‐scale experiments for
miRNA target identifiactions or in the bioinformatic analysis for conserved motif
discovery, indicating that their identification and functional study are
challenging. Here, we further analyze Ago HITS‐CLIP data focusing on the
identification of such atypical rules of miRNA target recognition and their
function in miRNA mediated gene silencing.
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Result
Evaluation of the performance of Ago HITS‐CLIP
First, we evaluated performance of our Ago HITS‐CLIP analysis which used seed
based approaches for predicting miRNA‐mRNA interactions. False positive rates
and specificity of our Ago‐miR‐124 ternary maps were assessed by comparing
them with the results from meta‐analysis of five published microarray
experiments, which sought to identify transcripts that were significantly
downregulated by miR‐124 overexpression in HeLa and other cell lines (Baek et
al., 2008; Hendrickson et al., 2008; Lim et al., 2005; Makeyev et al., 2007; Wang,
2006). Focusing on two sets – decreased transcripts enriched in direct targets (703
true set, negative fold change) and increased transcripts enriched in indirect
targets (575 false set, positive fold change), the false positive rate was estimated
as ~27% and specificity was ~92.5% (Figure 6.1), which achieved an
approximately 1.5 fold improvement in the performance of prediction relative to
bioinformatic prediction alone (~45% of false‐positives and ~67.5% of specificity
in the seed based prediction alone; Figure 6.1).

Next, we estimated the specificity of our method by comparing the number of
conserved seed matches in the bottom 20 versus top 20 Ago‐miRNAs in the 62nt
Ago footprint region (Figure 6.2A). The false positive rate was estimated as ~10%
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(~3.37 log2 fold ratio (top 20 vs bottom 20) = ~10 fold increase). In addition, a
similar method was applied to the top20 miRNA seed matches in 62nt Ago
footprint region (BC > 2 ; Figure 6.2B). ~12.5% of false positive rate was estimated
by comparing the number of conserved seed matches from the top 20 Ago‐
miRNA with the expected number by chance (among the P13 brain
transcriptome) in the Ago footprint region (~3.02 log2 fold ratio (observed vs
expected) = ~8 fold increase = ~12.5% false positive rate). By calculating false
positive rates depending on BC and peak height, we further found that even
under our lowest strigency conditions (BC > 2) our observed/expected ratios
were highly significant (Table 6.1).

The least stringent assumption (non

conserved 6‐mer seeds present in Ago‐mRNA clusters with BC > 2) gives a
maximum false positive rate of ~30%; the best assumption (conserved 8‐mers)
gives a false positive rate of ~5%, although clearly sensitivity is lower at this
threshold. Taken together, these estimates of specificity and false positive rates
(~93%, ~5‐27%, respectively) in our method indicated that experimental Ago
HITS‐CLIP data outperformed other approaches.

Although we used seed‐driven approaches to validate targets, not all Ago
binding need be constrained by these rules. When we estimated false negative
rates by comparing the number of Ago‐mRNA clusters with no predicted seeds
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in the top 20 Ago‐miRNAs, relative to the proportion of the top 20 Ago‐miRNAs
in the brain, 27% of Ago‐mRNA clusters (BC > 2) have no predicted 6‐mer seed
sites from among the top 20 Ago‐miRNAs families (comprising 88% of all Ago
miRNAs). Our seed‐driven approach yields an estimated false negative rate of
~15% (orphan clusters (27%) – Expected number of clusters from below top 20
(12%) = ~15%). This compares favorably with similar seed driven estimates of
false negatives rates of 50% to 70% made by other investigators (Baek et al., 2008;
Mourelatos, 2008; Selbach et al., 2008). However, we also recognized that even
though this seed‐based approach produced reasonable estimates for our false
negative rate, currently unknown miRNA binding rules/sites might affect our
false negative rate. Orphan clusters from false‐negatives might be bound by
miRNAs that follow other rules of binding, such as wobble/bulge matches
(Didiano and Hobert, 2006; Tay et al., 2008; Vella et al., 2004) or perfect matches
beyond seed (Grimson, 2007).

Bioinformatic evidences of miRNA‐mRNA interactions beyond seed
Although we observed a high correlation between the frequency of seeds in
mRNA tags and the frequency of miRNAs associated with Ago in the previous
analysis (Fig 5.1B and 6.2; R2 = ~0.61), there are some discrepancies showing
erratic shapes in Figure 6.2. To check the possibility that such discrepancies were
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caused by counting only the miRNA‐mRNA interactions within seed region, we
expanded the motif analysis to outside of seed region (Figure 6.3). The
normalized frequency of 6mer matches to every position of top 50 miRNAs
(Figure 6.3B) in the mouse brain showed that some miRNAs may interacts with
other regions. For example, miR‐708 (# 7 ranking) has enriched match sequences
in position ~8‐16 in Ago‐mRNA tags instead of seed matches (Figure 6.3C).
Hierarchical clustering of the same analysis, expanded to all brain miRNAs,
showed several distinct patterns of potential miRNA‐mRNA interaction regions
and estimated that ~50% of miRNAs may interacts with mRNA through regions
other than seed (Figure 6.3A). In addition, we could detect enrichment of 4mers
in position between ~13 and ~18 of miR‐124 although its fold ratio (~1.2 fold of
observed (obs) versus expected (exp) frequency), is less than the seed matches
(~1.4 fold of obs/exp; 14 fold of obs/exp in 7mer; Figure 6.4A‐B). Such an
observation correlates with 3’ supplementary or complementary sites whose
importance was shown in previous analyses (Brennecke et al., 2005; Doench and
Sharp, 2004; Grimson, 2007)

Focusing on Ago miR‐124 clusters and bulge/wobble sites, we searched in a
completely unbiased manner for all possible wobble and bulge variants of
miR124 seeds in our Ago‐mRNA footprints (Table 6.1). It is apparent from this
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analysis that there are some potential new rules from the Ago HITS‐CLIP data
that are not intuitively obvious. This includes some but not all wobble positions;
for example, wobble (4,5; GTGTTT) is slightly over‐represented in the data, while
wobble (4,5; GTTTTA) is very under‐represented.

Interestingly, G bulges at

position 5‐6 or 6‐7 are highly enriched and A bulges at position 5‐6 are
moderately enriched while C bulges at 5‐6 or 6‐7 are not. We next examined the
position and frequency of such conserved bulge sequences relative to the peaks
of Ago‐mRNA clusters and observed that G and A bulges showed many tags in a
tight peak region, while others did not (Figure 6.5). However, a limitation on
interpretation of the data is that miR‐124 bulge sequences could match to a
number of other miRNAs.

Identification of a bulge site in orphan clusters evident by miR‐124
transfection
To examine whether miR‐124 bulges are functionally important, we focused
further analysis on de novo Ago‐miR124 clusters, identified as clusters present in
miR‐124 tranfected HeLa but absent in the control HeLa cells. Linear regression
analysis of the de novo miR‐124 clusters identified G bulges together with seed
motifs (Figure 6.6A). Motif analysis in orphan clusters ( 921 clusters with no
miR‐124 seeds (BC=4)) also discovered the same set of miR‐124 G bulge sites
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(Figure 6.6.C). However, A bulges at position 5‐6 of miR‐124, which initially
appeared to be enriched in the brain set, were not identified in de novo miR‐124
clusters. In fact, A bulges match a number of other miRNAs, implicating that the
initial observation was an unavoidable artifact caused by heterogeneity of brain
miRNAs. Focusing on the analysis of a robust subset from de novo miR‐124
clusters, present in both mouse brain (BC>2) and miR124 transfected HeLa
(BC=4), we found that among de novo miR‐124 clusters, ~50% have classical seed
sites, ~15% G bulge sites, and ~35% remain “orphan” clusters (Figure 6.6B).

Experimental evidence of the functional relevance of the bulge sites was
achieved by luciferase reporter assay with various mutants of the G‐bulge site in
erythrocyte membrane protein band 4.1 (EPB41); only the G‐bulge site showed
statistically significant mir‐124 dependant repression (~1.3 fold repression
relative to the control, P<0.05, t‐test) comparable to the seed site (~1.4 fold
repression; Figure 6.7). Taken together, our data indicates that miRNAs may
recognize a specific type of bulge, preferentially located in position 5‐6 and these
site are likely to be functional as validated bulge site in EPB41.
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Discussion
Here we used Ago HITS‐CLIP data to identify the rules of miRNA target
recognition. We evaluated the performance of the Ago HITS‐CLIP method in
determining miRNA target sites in brain using seed based approaches and found
that large number (30~50%) of Ago‐mRNA clusters are orphans, which contain
no seed matches to miRNAs associated with Ago, implicating that large numbers
of target sites may be bound by miRNAs without seed pairing. In further
bioinformatic analysis, we could observe enrichment of bulge matches to miR‐
124 seeds, perfect seed matches and some matches to sequences outside of the
seed regions. Focusing on the analysis of de novo miR‐124 clusters identified by
Ago HITS‐CLIP in miR‐124 transfected HeLa cell, we confirmed that ~15% of
miR‐124 target sites contain G bulges between position 5 and 6 (5‐6) in the seed
and further validated that the G‐bulge target site in EPB41 is functional by
luciferase assay. Furthermore, we analyzed that 35% of de novo miR‐124 clusters
are still remain as orphans without any significant free energy change in
hybridization (Figure 6.8A) although the free energies from seed sites and G
bulges are significant (Figure 6.8A; relative to shuffled sequences). In addition,
other miRNAs such as let‐7 also has similar number of such bulge sites (5‐6) with
perfect seed sites in the brain (Figure 6.8B). In fact, a free energy calculation for
any nucleotide bulge between position 5 and 6 gives the same value. However,
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only a G bulge sequence can also make another 5 consecutive perfect match
starting from position 2. The free energy calculation of this pair is lower than the
free energy from the bulge pair. Therfore, preference of G position in the bulge
may be caused by free energy contribution from the 5 consecutive perfect match,
another optimal pairing from G bulge sequences. Similarily, A bulge in let‐7 can
make the same 5 consecutive perfect matches and it is the most enriched bulge in
let‐7 (14%).

Taken together, we demonstrate that miRNAs can recognize

functional target sites beyond seed and preferentially bind to certain type of
bulge (5‐6) sites. Understanding of such binding rules using Ago HITS‐CLIP is
increasingly important for studying miRNA functions and as well as designing
siRNAs for basic research and therapeutics.

Contributions
All bioinformatic analysis, construction of luciferase reporter and luciferase assay
were done by Sung Wook Chi.
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Figure 6.1. Performace of Ago HITS‐CLIP estimated by Meta‐analysis of five
microarray studies in miR‐124 overexpression.

We compiled 1278 brain expressed transcripts from a meta‐analysis of five
microarray experiments which identified transcripts significantly downregulated
by miR‐124 overexpression in cell lines (see Supplementary Methods)

The

performance of Ago‐miR‐124 ternary cluster predictions was assessed by
comparing it with miR‐124 seed prediction in two sets – decreased transcripts
enriched in direct targets (703 true set, negative fold change) and increased
transcripts enriched in indirect targets (575 false set, positive fold change). The
true positive rate or specificity was calculated as indicated in black box insets
(Ago miR‐124 ternary cluster prediction; 73% true positive rate and 92.5%
specificity, miR‐124 seed prediction; 55% true positive rate and 67.5% specificity).
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Figure 6.1
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Figure 6.2. Statistical analysis of false positive rates for Ago HITS‐CLIP
analysis

A. Cumulative frequency of top (N) Ago‐miRNA 6‐mer seed sequences,
compared to the frequency of the bottom (N) Ago‐miRNA 6‐mer seeds, in Ago
footprint regions. B. Cumulative frequency as in (A), but comparing the observed
vs. expected seed frequencies for the top 30 Ago‐miRNA in Ago footprint
regions. Both datasets suggest that the correlation between the top 20 miRNAs
and Ago‐mRNAs is robust as a group, and that correlations likely extend out
significantly further. In addition, the shape of the cumulative curve (e.g. (B))
suggests variability among individual miRNA ternary maps.
conserved seed sequences in calculation of cumulative frequencies.
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We used

Figure 6.2

A

B
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Figure 6.3. Analysis of miRNA matches from different positions in Ago mRNA
tags

A.The frequencies of conserved 6mer matches from different positions of brain
expressed miRNAs (confirmed to be expressed by Ago miRNA CLIP in P13
mouse brain) in the sequences of Ago mRNA clusters (BC>2) are calculated,
further normalized by mean value of all such frequencies in each miRNAs (log2
ratio centered by mean value; B), used for hierarchical clustering of the miRNAs
and visualized as a heatmap and tree (A). miRNAs showing enrichment of their
motifs in seed region (position 1‐8) are indicated as group (a blue lined group or
a pink colored tree). C.The same analysis as (A) but only for top 50 miRNAs
(miRNA frequency ranking from the Ago CLIP) without performing hierarchical
clustering
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Figure 6.3
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Figure 6.4. Motif analysis of Ago mRNA clusters

A. The frequencies of 7mer matches from the different positions of miR‐124
(observed frequency; obs) are divided by expected frequencies (estimated
frequencies in p13 brain transcriptome; exp) and plotted depending on the
different position of miR‐124. B. The same analysis performed in (A) with 4mer
matches. Significantly enriched motifs (>1.2 fold) are highlighted as blue for seed
region and red for other region. A top enriched motif from MEME analysis in
Ago mRNA clusters (BC>5; C) and orphan clusters (D). A bulge sequence is
marked by red dot.
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Figure 6.4
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Figure 6.5. Distribution of mRNA tags correlates with some bulge matches to
miRNAs from Ago CLIP.

The position of conserved 7mer bulge matches to miR‐124 (A‐B with different
sequence in bulge position; indicated as lower cases, bottom panel; each is
represented by a different color) were plotted relative to peak position of all Ago‐
mRNA clusters (BC > 2). Top panel; distribution of mir‐124 seed matches (plotted
relative to cluster peak, normalized to number of clusters; blue graph); pale color
indicates standard deviation.
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Figure 6.5
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Figure 6.6. Identification of a bulge match to miR‐124 in de novo miR‐124
clusters from Ago CLIP.

A. We correlated all possible 6 to 8‐mer motifs present in de novo Ago‐mR124
clusters (BC=4, identified from Ago CLIP performed in miR‐124 transfected
versus control miRNA transfected HeLa) with cluster height (log2(maximum tag
number) per cluster), using the MatrixREDUCE linear regression model:
(http://bussemaker.bio.columbia.edu/software/MatrixREDUCE/).

The

most

enriched motifs selected by default parameters (except –max_gap=0) are shown.
B. Distribution of conserved robust Ago‐miR124‐clusters, clusters present in both
mouse brain (BC>2; right panel) and miR124 transfected HeLa (BC=4; left panel)
is analyzed by three categories, clusters with miR124 seed matches, bulge
matches (a bulge between position 5‐6) and others.C. Motif discovery analysis
using MEME program in orphan clusters (with no miR‐124 seeds) identified the
G bulge (G bulge between position 5‐6).
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Figure 6.6
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Figure 6.7. Validation of miR‐124 bulge sites in EPB41 by luciferase reporter
assays.

A.Conserved de novo Ago‐miR‐124 clusters (overlapping with Ago‐mRNA
clusters in P13 mouse brain) in 3’UTR of erythrocyte membrane protein band 4.1
(EPB41). The locations of miR‐124 seed matches are indicated as red lines. Black
bar indicated the region (104nt) containing a G bulge match, inserted into the
luciferase reporter. Bottom panel shows wild type and mutant sequences used
for the luciferase reporter assay. B. Normalized results (renilla reporter lucifease
activity is normalized by firefily luciferase activity) from the luciferase reporter
assay with the G‐bulge sequence, and other mutants (perfect seed match and T
bulge, A bulge and C bulge matches). The assays are performed in miR‐124
tranfected versus control miRNA transfected HeLa cells (n=3; three replicates of
experiments with different HeLa cell batches). Statistically significant results are
indicated as asterics (P<0.05; t‐test).
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Figure 6.7
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Figure 6.8. Free energy calculation of de novo Ago‐miR‐124 sites and analysis
of buge matches to let‐7 in Ago‐mRNA clusters.

A.Calculations of free energies from three types of clusters (Figure 6.6B)
annealing to miR‐124. The free energies are calculated by RNAduplex (Hofacker,
2003)(average values are indicated as the same color in Figure 6.6B) and
compared with the shuffled sequences (100 times; average values are indicated
as gray bar). P‐values from t‐test are indicated. B.Numbers and fractions of the
different bulge matches (a bulge between position 5 and 6) and the seed match to
let‐7 in Ago mRNA clusters (P13 mouse) are shown.
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Figure 6.8

186

Table 6.1.

Biolologic complexity and peak height analysis of Ago mRNA

clusters.
Effect of varying BC and peak height on Ago‐HITS‐CLIP map predictions. We
evaluated enrichment of seeds (estimated by calculating Ago‐miRNA seed
sequences (observed vs. expected) in Ago‐mRNA footprints from P13 mouse
brain transcripts) for the #8 ranking (miR‐124) and the #18 ranking (miR‐19)
miRNAs using the indicated thresholds in BC and peak height. We found that
even under our lowest stringency conditions (BC > 2 or peak height > 2), our
observed/expected ratios were highly significant. The least stringent assumption
(6‐mer seeds present in Ago‐mRNA clusters with BC > 2) gives a maximum false
positive rate of ~30%; the best assumption (conserved 8‐mers) gives a false
positive rate of ~5%, although clearly sensitivity is lower at this threshold.
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Table 6.1
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Table 6.2. Wobbles and bulges matching to miR‐124 seeds in Ago mRNA
clusters.

Observed vs. expected frequencies for all possible wobble and bulges in miR‐124
seed sequences present in Ago‐mRNA clusters.
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Table 6.2
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CHAPTER VII. GENERAL DISCUSSION

The value of HITS‐CLIP
When the human genome was decoded, the lower than expected number of
genes prompted interest in RNA complexity generated by RNA regulation such
as alternative splicing, polyadenylation, and post‐transcriptional control of gene
expression. Such RNA regulation is often controlled by RNA‐binding proteins
(RNABPs) or non‐coding RNAs including microRNAs (miRNAs), but their
comprehensive study has lagged behind studies of DNA regulators because of
lack of a precise genome‐wide method for detecting RNA‐protein interactions.
To overcome such limitations, we have developed an unbiased, genome‐wide
method to characterize RNA–protein interactions in living tissues called HITS‐
CLIP

(high‐throughput

sequencing

of

RNAs

isolated

by

crosslinking

immunoprecipitation). We demonstrated its potential by applying it to mouse
brains and characterized the binding sites of the neuronal alternative splicing
regulator, Nova, and decoded the target sites of miRNAs through the
identification of Argonaute (Ago) associated RNAs.
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Transcriptome‐wide maps of functional RNABP‐RNA interactions generated by
HITS‐CLIP yield new insights into rules by which RNA complexity is regulated.
Our Nova HITS‐CLIP analysis has generated compelling evidence that the
position of RNABP‐RNA interactions within primary transcripts dictates the
functional outcome of alternative pre‐mRNA processing events (Licatalosi et al.,
2008). HITS‐CLIP showed that binding of RNABPs within an alternative exon or
the flanking upstream intronic sequence is generally associated with exon
skipping, whereas binding of RNABPs to the downstream intronic sequence is
generally associated with exonic splicing. These studies were presaged by
bioinformatic analyses of Nova regulated RNAs (Ule et al., 2006), but such
studies were unable to definitively distinguish direct from indirect Nova targets,
one of the powerful advantages of HITS‐CLIP.

The unbiased nature of the functional RNA‐protein interaction maps can also
allow completely unexpected discoveries. Based on the identification of Nova
binding in miRNA‐coding transcripts, we showed evidence that Nova may have
an additional function in regulating processing of miRNAs. Nova HITS‐CLIP
analysis also led to the recognition of a role for Nova in regulating alternative
polyadenylation, derived from the observation of Nova binding near poly(A)
sites (Licatalosi et al., 2008). Furthermore, HITS‐CLIP analysis was extended to
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the study of ternary interactions between an RNABP (Ago), RNA and miRNAs,
generating a genome‐wide map of microRNA binding sites and yielding new
rules of RNA regulations. Such findings show the power of HITS‐CLIP method
in yielding new insights into additional function of RNABPs and miRNAs
regulating RNA complexity.

Regulation of miRNA processing by Nova
Transcripts encoding miRNAs called primary miRNAs (pri‐miRNAs), are known
to be first processed into precursor miRNAs (pre‐miRNAs) by the multipotrein
complexes called microprocessor, consists of Drosha and DGCR8, then into
mature miRNAs (Kim et al., 2009b). However, the regulatory mechanisms of
miRNA processing are not well known. There are a few reports that RNABPs
have roles in the regulation of miRNA processing. It was reported that hnRNP
A1 binds to pri‐miR‐18a and facilitates its processing (Guil and Caceres, 2007)
and that KH‐type splicing regulatory protein (KSRP) is a component of both
Drosha and Dicer complexes, regulating the processing of subset of miRNAs
(Trabucchi et al., 2009). In our study using Nova HITS‐CLIP, we also showed
that Nova indirectly upregulates miR‐770 by inducing an alternative splicing
variant containing miR‐770 and also directly activate processing step of pri‐miR‐
380
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These findings raise some interesting questions and potential future directions
for research. The first question is about the mechanism by which Nova activates
Drosha in processing pri‐miR‐380. We can generate the hypothesis that miR‐380
may require Nova to form a structure allowing recognition and processing by
Drosha and DGCR8 complex (also known as microprocessor). In fact, it is known
that microprocessor needs a specific structure, ~33 basepairs (bp) of pri‐miRNA
stem structure with flanking single stand RNA (ssRNA) located on

11bp

distance from the stem‐ssRNA junction (Han et al, Cell, 2006). By recruiting
Nova, pri‐miR‐380 may form this structure more easily and then be recognized
and processed by the microprocessor. It has been shown that Nova can dimerize
by the interaction through its KH domains (Lewis et al., Cell, 2000), suggesting a
potential action whereby Nova may bind at two different locations on RNA and
dimerize, and in this way facilitate a formation of an RNA loop of pri‐miRNA,
For example, two putative YCAY elements (CCAT, CCAC) are located at the
each of strands forming stem structures of pre‐miR‐380. A further idea is the
potential existence of other, as yet unidentified pri‐miRNA structures, which
might form and be processed only upon the binding of Nova. Furthermore, Nova
might recruit other proteins which might have RNA chaperone activity for pri‐
miRNA structure. Further experiments to test this hypothesis might consist of
determining direct interactions of pri‐miR‐380 with Nova, secondary structure of
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the pri‐miR‐380 hairpin and efficiency of processing by microprocessor in the
presence versus absence of Nova.

Evaluation of Ago HITS‐CLIP analysis
Gene silencing induced by miRNAs in the regulation of gene expression is
important for many biological function and pathogenesis of diseases. Although
various efforts have been tried to determine miRNA targets based on
computational approaches (Rajewsky, 2006) and were recently combined with
large‐scale experiments (Baek et al., 2008; Lim et al., 2005; Selbach et al., 2008),
they are hampered by high false positive rates (~40‐66%; detail in following
discussion section) because the target site sequences are short and occur often in
the genome. This problem has been overcome by our study using Ago HITS‐
CLIP method. We redesigned the HITS‐CLIP method focusing on miRNA and
mRNA interactions with Ago, a ubiquitous core component with endonuclease
activity in RNA‐induced silencing complex (RISC), and used this method to
decode a precise map showing high resolution of miRNA binding sites in brain
mRNA transcripts. The importance of this method is that it is generally
applicable and it can be used for understanding the functional role of miRNAs
and as well as determining target sites for RNA interference therapy on clinically
relevant mRNAs.
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The miRNA‐mRNA interaction maps generated by Ago HITS‐CLIP have the
potential to advance our understanding of miRNA regulation. In the current
setting, Ago HITS‐CLIP generates two collections of tags, one sampling the set of
miRNAs that are expressed and actively incorporated into Ago protein complex
and the other sampling the mRNAs at the sites of interaction with one or more of
these active miRNAs. By generating this collection, it substantially reduces set of
miRNAs and search space for their binding sites by defining a ~45‐60‐nucleotide
Ago footprint based on the distribution of mRNA tags (Figure 5.1). Although
Ago HITS‐CLIP analysis used the same “seed driven” approaches as other
bioinformatics prediction, it outperformed bioinformatic predictions alone or
combined with large‐scale experiments (~93% specificity, ~13‐27% false positive
rates and ~15‐25% false negative rates ; estimated by miR‐124 datasets). The
following discusses more details about the performance of Ago HITS‐CLIP for
miRNA‐mRNA interaction maps (also called “Ago ternary maps”) focusing on
its specificity and sensitivity.

‐Specificity of Ago ternary maps
To compare the specificity of Ago ternary maps from HITS‐CLIP with other
approaches, false positive rates from other seed based methods combining
proteomic approaches were first estimated (Baek et al., 2008; Selbach et al., 2008).
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They were estimated as ~40% (Mourelatos, 2008) or ~66% (based on their reports
that two‐thirds of the predicted targets appeared to be nonresponsive to miR‐223
loss in neutrophils (Baek et al., 2008)). This higher number of false positives is
also in agreement with findings from two other approaches using purification of
miRNA‐protein complexes ( >50% (Hammell, 2008) or ~70% (Easow et al., 2007);
based on reports about ~30% of seed‐containing true positives). We previously
estimated the performance of Ago HITS‐CLIP analysis as ~93% of specificity and
~5‐27% of false positive rates and bioinformatics alone as ~67.5% of specificity
and ~45% of false‐positives (detail analysis in chapter 6). Therefore we can
conclude that the Ago ternary maps (with a false positive rate of ~6.8‐27%;
majorly estimated by miR‐124 datasets) achieved a minimum of a 1.5‐fold, and a
maximum of a 10 fold improvement in false‐positives relative to other
approaches (~40‐70%).

We further analyzed observed versus expected frequencies for each seed match
from the top 30 miRNAs in Ago‐mRNA clusters (BC>2). Some apparent false‐
positives are in this group, as estimated by observed versus expected seed
enrichment (e.g. miR‐125, miR‐708 and miR‐324‐3p); this is also apparent in the
erratic shape of the curves in Figure 6.1. However, even within the top 20 robust
miRNA set, we do not know the rules of miRNA binding (other than “classical”
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seed rules), and this impacts upon the false positive set. In addition, even
without including seed conservation, if we examine observed versus expected 8‐
mer seed frequency of miR‐125, one of the miRNAs showing apparent false‐
positives with 6mer seeds, then we again see statistically significant seed
enrichment in Ago‐mRNA clusters (data not shown). Moreover, this data makes
biologic sense, since miR‐125 is expressed in the brain, and the GO targets
identified match the known biology (with roles in cytoskeletal regulation; Figure
5.7 and 5.8).

‐ Sensitivity of Ago ternary map
The issue of how to estimate sensitivity and false negatives is clearly important,
but it also must be recognized that this is a difficult issue, because there are in
fact no gold standard “true” datasets upon which to answer this question other
than the dataset for miR‐124. Therefore, we focused our attempts to estimate
false negatives on the set of miR124 targets validated by Hannon and colleagues
(Karginov et al., 2007). Unfortunately, this set is only 22 deep. Nonetheless, this
analysis yielded a false negative rate of 6/22~25%.

For transcripts of even

moderate abundance (normalized probes intensity >700), we identified all 10/10
predicted targets (Table 5.3). Moreover, if we examine raw clusters (i.e. without
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using in silico normalization), we identified 21/22 predicted targets (~0.05% false
negative rate).

We also could address sensitivity from this analysis. For the 6 potential false
negatives in Table 5.3, transcript levels were low (normalized probe intensity
was < 700 for each transcript (excluding Tom1l1, which appears to have an
unusual antisense transcript expressed in brain covering the 3’ UTR)). Of all 12
transcripts in Table 5.3 with transcript levels at or below 700, 7 were identified,
while 5 were missed, suggesting that for the rarest transcripts, we detected 58%
of true positives. Classifying our data in this fashion, we have very low false
negative rate estimates (10/10 positives) for over 50% of the transcriptome (> 700;
versus median expression level = 771, and average expression level ~1,255). We
also compared the recovery of transcripts as a function of abundance versus our
ability to identify miR‐124 targets. This result (Figure 7.1) confirms those
observed on a smaller scale in Table 5.3, which is that low abundance transcripts
are (not surprisingly) recovered less efficiently.

In addition, we can also estimate the sensitivity of the Ago‐mRNA map as it
relates to miRNA abundance. We readily detected miRNAs present at less than
1% of the total population (Figure 4.3) and the seed signal for these miRNAs
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showed approximately equal enrichment between the top of this list (e.g. #1,
miR‐181a, 6% of total Ago‐miRNA, Figure 4.3, shows 1,190 sites, and a 1.7 fold
enrichment in the Ago‐mRNA footprint region) and the end of this list (#29, miR‐
23, <0.36%, which shows 1,036 sites, and a 1.4 fold enrichment). Therefore, the
top 20 miRNAs provide a robust set of enriched seed sequences in the Ago‐
mRNA footprints (Figure 7.1), and suggests that Ago‐HITS‐CLIP is likely to
work well for additional miRNAs beyond this set. Another way of estimating the
false negative rate is by comparing the number of Ago‐mRNA clusters with no
predicted seeds in the top 20 Ago‐miRNAs, relative to the proportion of the top
20 Ago‐miRNAs in the brain (as described in chapter 6). 27% of Ago‐mRNA
clusters have no predicted seed matches among the top 20 Ago‐miRNAs families.
Such orphan clusters estimated ~15% of false negative rate but also indicated that
there might be other rules of binding, which prompted further analysis for
miRNA target recognition beyond seed pairing (chapter 6)

miRNA target recognitions beyond seed.
Although we observed high correlation between the frequency of seeds in
mRNA tags and the frequency of miRNA associated with Ago, there appears to
be a disparity: the hexanucleotide that appears most frequently in Ago‐mRNA
tags (seed match from #9 ranking miR‐124) is not the one corresponding to the
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miRNA that appears most frequently in AGO‐miRNA tags (#1 ranking miR‐30)
(Figure 5.1B and Table 5.1). We found that a miR‐124 seed match is ~1.33 fold
more frequent than a miR‐30 seed match (51,461 total 6‐mers for miR‐124, vs.
38,752 for miR‐30 in P13 mouse brain transcriptome), meaning that there are
more miR‐124 potential binding sites in transcripts. We initially interepreted this
correlation as being consistent with a relative increase in miR‐124 bound sites.
However, it is also possible that there is underlying biologic regulation that we
do not understand, or that there are additional rules of binding that are not
apparent in current seed centric analyses. Actually, we observed some apparent
abundant miRNAs (e.g. #7 ranking miR‐708) showed enrichment of sequence
matches from regions other than seed (e.g. position ~8‐16 in miR‐708) in mRNA
tags (Figure 6.3C). In general, we observed that ~50% of brain expressed miRNAs
do not have their seed matches enriched in Ago‐mRNA tags (Figure 6.3). Such
miRNAs including miR‐708 should be further investigated to confirm their new
target recognition rules by analyzing de novo miRNA target sites identified by
Ago HITS‐CLIP in the cell where each of individual miRNA is transfected.

By analyzing de novo miR‐124 clusters (clusters only identified by Ago HITS‐
CLIP in miR‐124 transfected HeLa cell), we found that ~15% of miR‐124 target
sites contain G bulge (G between position 5 and 6 of seed match) in addition to
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~50% of the seed match sites (Figure 6.6). Other nucleotide bulges (A, U, or C ) at
the same position (between position 5 and 6 of seed match) are neither
statistically enriched in bioinformtic analysis nor responsive to miR‐124
expression in luciferase reporter assays (Figure 6.6 and 6.7). In fact, a free energy
calculation for any nucleotide bulge between position 5 and 6 gives the same
value ( ‐5.6 kcal/mol ; the free energy calculated for pairing it with miR‐124 seed
(position 2‐8) by RNAduplex (Hofacker, 2003)). However, only a G bulge
sequence can also make another 5 consecutive perfect match starting from
position 2. The free energy calculation of this pair is ‐6.8kcal/mol, lower than the
free energy from the bulge pair (‐5.6kcal/mol). Based on computational analysis
of some validated miRNA target sites, seed annealing is thought to initiate
miRNA‐mRNA duplex followed by further annealing which stabilizes
thermodynamics, indicating that the free energy of seed pairing is more
important than the free energy of the entire pairing (Rajewsky and Socci, 2004).
Therfore, we can make a hypothesis that preference of G position in the bulge
may be caused by free energy contribution from another optimal pairing from G
bulge sequences and this hypothesis need to be further tested by luciferase
reporter assays with mutant constructs. Although additional G bulge rule was
accounted, ~35% of orphan clusters are still remained as de novo miR‐124 target
sites. Surprisingly, we could not find any consensus sequence or significant free
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energy change by annealing with miR‐124 in these remaining orphan clusters.
Recently, it is reported that several miR‐24 targets also contain functional
“seedless” miRNA recognition elements without any consensus motifs and
signigicant free energy changes (Lal et al., 2009) like our results, suggesting that
our remaining orphans still may be associated with functional binding sites
through complicated unknown rules, which should be further analyzed through
more sophisticated bioinformatic analysis.

Improvement of Ago HITS‐CLIP
The identification of the orphan clusters from Ago HITS‐CLIP analysis prompted
us to think of further improvement of bioinformatic analysis in current HITS‐
CLIP method. In the processing step of Ago‐mRNA tags, we used a simulation
approach called “in silico random CLIP” to simulate distributing sequence tags
across messenger RNAs based on expression levels of mRNAs. We measured
abundance of transcrtipts by performing microarray instead of “RNA‐Seq”
technique, high‐throuput sequencing method for measuring expression levels of
transcripts. Unfortunately, RNA‐Seq was not established as a method until very
recently, and was not available when Ago HITS‐CLIP method was developed.
Although RNA‐Seq is better than microarray in terms of accuracy and sensitivity,
current study suggests that microarray (exon array) is still highly correlated with
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RNA‐Seq data (probe intensity vs sequence freq(log2)) (Marioni et al., 2008).
However, it is very likely that there is bias related to how well the probes on the
exon array can measure transcripts. As RNA‐Seq is becoming an important tool
going forward particularly as the depth of sequencing increases, in silico random
CLIP algorithm should use RNA‐Seq for measuring abundance of transcripts in
the future. Using RNA‐Seq will result in actual counts for the whole transcripts
and be motivated as these counts should be more comparable across genes.

In addition to improve normalization process, development of a computational
analysis will be required to further identify motifs or rules of miRNA recognition
especially for remaining orphan clusters. As mentioned before, Ago HITS‐CLIP
method can be coupled to any computational method for finding targets and
improve the quality of the predictions. Bioinformatic approaches should be
improved to identify critical features of the target sequences such as positions of
consensus sequences, combinatorial rules of regulatory RNA elements,
secondary structures of the RNA binding site, and regulatory rules of target
RNAs in terms of functional networks. Such rules and findings may achieved by
using machine learning algorithms, learning from the various features obtained
from various bioinformatic tools such as evolutional conservation (Multiz5way),
enrichments of sequences (MEME), local RNA folding (mFold, RNAfold) and the
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functions of target genes (EASE, GOminer) (Bailey and Elkan, 1994; Hofacker,
2003; Hosack et al., 2003; Thomas et al., 2003; Zeeberg et al., 2003; Zuker, 2003).
Our current Ago HITS CLIP analysis still depends on bioinformatic predictions
to pair‐up miRNAs with collected mRNA target sites, which can not definitively
avoid from false‐positives and false‐negatives. If we can improve current Ago
HITS‐CLIP method to experimentally pair‐up miRNA with mRNA target
sequences, it would dramatically reduce false‐postives. As miRNAs have 5’
phosphates which buried into Mid domain of Ago (Wang et al., 2008a), we may
be able to only dephosphorylate 3’ phosphates of mRNA fragments generated by
an RNaseA treatment and induce subsequent ligation of a protected 5’ phosphate
of miRNA with a new 3’ hydroxyl group of an mRNA fragment. A prerequisite
condition for this ligation might be crosslinking of both a miRNA and an mRNA
fragment to Ago. In the beginning, we did not expect to see much evidence of
Ago, miRNA and mRNA crosslinked together, because the efficiency of
crosslinking is quite low which we estimated in Nova HITS‐CLIP as on the order
of 1% (Unpublished data). Thus the frequency of crosslinking Ago to both a
miRNA and an mRNA would be estimated to be ~0.01%, an uncommon event.

However, we did in fact observed that the bigger complexes (130kD, Ago‐mRNA
complex) contained a subset of miRNAs (~22nt) and shorter mRNA tags (~30nt)
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(Figure 4.2C) and further confirmed similar results from distribution analysis of
length of tags in high‐throuput sequencing data (Figure 7.2A‐B). Although we
amplified RT‐PCR products from average ~50nt RNA‐protein complex (130kD,
crosslinked Ago‐mRNA complex) and subsequently purified ~50nt PCR
products for high‐throughput sequencing, we still got ~10% of miRNA tags
(~20nt) and also ~10% of putative co‐crosslinked mRNA tags (~30nt) (Figure
7.2A‐B). Such observations are absent in average ~50nt RNA‐Nova complex.
These observations implicates that actual co‐crosslinking efficiency may be
greater than ~10% in Ago HITS‐CLIP. Therefore, these hypothesis are worth
further experimentally considered and validated to improve the Ago HITS‐CLIP
method in the future. However, it is also possible that the ~20nt tags were
smeared on the gel from the lower band, and that the ~30nt tags were stochastic
variants running trapped with the larger complexes.

Ago mRNA clusters outside of 3’ UTR.
When Ago mRNA tags were overlaid with gene annotations, several patterns
emerged (Figure 4.10C‐D). As expected, a substantial portion (~40%) of Ago‐
bound tags were in 3′ UTRs where miRNA activity is known to have high
efficacy. Some ~8% (one‐fifth of the ~40%) were actually outside of the UTR but
within 10kb downstream, regions likely to harbor unannotated 3′ UTRs.
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Unsurprisingly, very few Ago‐bound tags were in 5′ UTRs (~1.9% of clusters in
transcripts; ~6.8% of expected frequency; Figure 4.11). Although those sites in
5’UTR are very few, they are likely to be functional based on the observation that
they are biologically reproducible (BC=5) and the report that miRNA‐guided
repression is equally efficient when sites are located in the 5ʹ or 3ʹ UTRs of
reporter transcripts (Lytle et al., 2007). It is worth testing the efficiency of these
sites in 5’UTR by performing luciferase reporter assays.

However, a substantial fraction of tags fell in coding sequences (CDS) (~25%),
introns (~12%), and non‐coding RNAs (~4%), suggesting that miRNA activity
occurs in these regions as well. Recently, there are several reports supporting
functional miRNA target sites in CDS (Duursma et al., 2008; Forman et al., 2008;
Lal, 2008; Shen et al., 2008; Tay et al., 2008). In C. elegans, it is reported that Ago
transports siRNAs from the cytoplasm to the nucleus (Guang et al., 2008) and in
human, miR‐29b is shown to predominantly localize to the nucleus (Hwang et al.,
2007). We also observed that Ago mRNA clusters in introns often contain seed
matches from highly expressed miRNAs (data not shown). Therefore, Ago
ternary complex may localize to nucleus, bind to introns of the targets and
associated there to repress the targets possibly through endonuclease activity of
Ago. By cleaving the targets at the pri‐mRNA form, it may assure the repression
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of the targets which need to be translationally repressed also in the cytoplasm.
Ago‐RNA bindings, detected in non‐coding RNAs, could be the functional target
sites of miRNA to degrade such non‐coding RNAs which may have critical roles
in biological function or the regulation of gene expression. However, they also
could be considered as non‐coding RNAs interacting with Ago to directly
regulate the RISC activity, primary transcripts encoding miRNAs or other new
class of small RNAs which could be loaded on RISC, since we can not
discriminate whether RNAs from Ago CLIP experiments are effector (like
miRNAs) or targets (like miRNA target mRNAs). It would be interesting to test
such a hypothesis by reporter assay or biochemical assay in the future. In
addition, these unexpected locations of miRNA binding may offer additional
insights into the mechanisms of miRNA regulation, which also need to be further
examined by HITS‐CLIP.

miR‐124 target regulation elucidated by Ago HITS‐CLIP
We used Ago HITS‐CLIP to identify a brain map of transcripts regulated by miR‐
124, a miRNA proposed to play a role in establishing and perhaps maintaining
neuronal identity, in part by suppression of transcripts that encode proteins that
suppress neuronal identity. The latter group has been suggested to include
Cdtsp1, its target protein REST, and the RNABP Ptbp1, although screens to
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distinguish direct from indirect targets have relied on bioinformatic analysis of
miR‐124 binding sites. Our data helps to confirm that Ctdsp1 and Ptbp1 are
direct miR‐124 targets, while refining the target sites to which Ago‐miR‐124
actually binds. The absence of Ago binding sites in REST at P13 mouse brain
(data not shown) is consistent with REST playing an indirect (from an Ago
perspective)

role

in

neuronal

identity.

Interestingly,

we

found

that

overexpression of miR‐124 can induce Ago to bind to validated miR‐124
regulatory sites, but also that this binding often precludes Ago binding to sites
that would otherwise be occupied, perhaps reflecting competition between a
limited capacity for miRNA binding on a given 3’ UTR (Khan et al., 2009). More
generally, the resolution of Ago regulated miR‐124 pathways suggests that Ago
HITS‐CLIP can be used to define the role of miRNAs and the target transcripts
implicated in a variety of biologic contexts, such as miR‐133b in dopaminergic
neurons (Kim et al., 2007), lsy‐6 in neuronal left/right axis determination
(Johnston and Hobert, 2003b), or the general role of miRNAs in cerebellar
development (Schaefer et al., 2007).

Interplays between RNABPs and miRNAs
Ago HITS‐CLIP offers dramatic improvement in identifying miRNA target sites
especially for transcripts with highly conserved 3‘ UTRs, which often have many

209

“predicted” miRNA binding sites because so many computational methods rely
on conservation. For example, the 3’ UTRs of the neuronal RNABPs Ptbp2,
Nova1, and Fmr1 are highly conserved and have many predicted miRNA sites
(in some cases over 50 using robust algorithms such as TargetScan or PicTar), but
each has only single Ago‐mRNA CLIP clusters (Figure 5.9). More generally, Ago
HITS‐CLIP demonstrates that the level of miRNA selectivity is very high such
that on average transcripts have between 1‐3 major Ago binding sites in a single
tissue (Figure 5.3, 5.6 and 5.9).

This implies that additional factors may

contribute to the selectivity of miRNA‐seed recognition. We find no evidence
that Ago‐mRNA binding sites themselves have a specific sequence preference
(data not shown), suggesting that specific sites may be protected or made
accessible by the binding of other sequence‐specific RNABPs. Such a mechanism
might provide a means of dynamically regulating miRNA binding and hence
miRNA‐mediated RNA regulation itself.

Based on the HITS‐CLIP results and some reports about miRNA target
regulation by RNABPs, we can generate models suggesting the mechanisms and
effects of the interplay between RNABPs and Ago bindings on miRNA targets
(Figure 7.2). RNABP bindings may be competitive to miRNA bindings (Figure
7.2A) like reports that HuR, an AU‐rich‐element (ARE) binding protein, binds
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CAT1 and inhibits its repression by miR‐122 (Bhattacharyya et al., 2006b). The
same result was observed in Dead end 1 (DnD1) that it also protects target
mRNAs from miRNA‐mediated repression (Kedde et al., 2007b). RNA binding
may activate miRNA mediated repression through cooperative interactions with
target transcripts, through increasing local concentration of Ago complex (Figure
7.2B) or resolving a secondary structure hindering access of Ago complex to a
miRNA target site (Figure 7.2C). This model is supported by the observation that
binding of HuR to 3’UTR of c‐Myc recruits let‐7‐loaded RISC and repress c‐Myc
expression (Kim et al., 2009a). Furthermore, RNABP may be involved in
switching of miRNA mediated repression to activation (Figure 7.2D).
Interestingly, it was shown that ARE recruits miR‐369‐3 associated with RISC
together with a RNA binding protein called fragile X mental retardation‐related
protein 1 (FXR1) to tumor necrosis factor‐alpha (TNFalpha) mRNA and activates
translation (Vasudevan et al., 2007). However, a major limitation of this study is
lack of understanding of location of binding sites of both RNABPs and miRNAs
on target transcripts, which is prerequisite to understanding mechanisms. Such
mechanisms, which may be assessed by overlaying HITS‐CLIP maps of different
RNABPs and Ago‐ternary compelx with combination of genetic approach
(RNABP null mice vs wild type) and experiments for measuring miRNA‐
mediated repression such as microarray (Lim et al., 2005) or SILAC (Baek et al.,
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2008; Selbach et al., 2008), could provide a means of dynamically regulating
miRNA binding and regulation (Figure 7.2).

Conclusion
In conclusion, we developed HITS‐CLIP to comprehensively understand RNA
complexity regulated by RNABPs and miRNAs. HITS‐CLIP offers a number of
new opportunities to explore RNABP and miRNA biology. Most significantly,
we demonstrate that bioinformatic analysis of the data from a single set of
experiments can identify the target sites on transcripts in a given biologic tissue
with great specificity (~92.5%; ~15% of false negatve rates from Ago HITS‐CLIP).
Moreover, the ability to simultaneously assess multiple miRNAs offers a means
of understanding combinatorial control of target RNA expression. Identification
of specific binding sites also offers the possibility of specifically disrupting or
enhancing miRNA or RNABP activity, for example with interfering or stable
RNA analogues (Elmen et al., 2008). The unbiased nature of HITS‐CLIP offers
the possibility of confirming and discovering new biology; unexpected findings
that the processes of some miRNAs may be regulated by Nova and the relatively
large number of Ago complex bind in coding sequence, as well as some in
introns, suggesting unexplored functions for Ago‐miRNA complex. Moreover,
not all Ago mRNA clusters correspond to known seed sequences (23% Ago foot
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print regions have no conserved seed sites among all Ago‐miRNAs) which lead
to identifying miRNA recognitions beyond seed pairing. However, remaining
~35% of orphans from Ago miR‐124 clusters suggest that further improvement of
Ago HITS‐CLIP analysis may help uncovering additional rules dictating Ago‐
miRNA‐target interactions. Such specificity may be determined, in part, through
additional cis‐acting RNA‐protein complexes (Bhattacharyya et al., 2006; Kedde
et al., 2007a), and thus overlaying Ago HITS‐CLIP maps with those for other
RNABPs (Licatalosi et al., 2008) would be informative to understand RNA
regulations and complexity
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Figure 7.1. Ago ternary maps depending on the level of transcripts and
distributional analysis of the length of CLIP tags.
A. Fraction of total p13 brain transcripts (blue line) or transcripts with Ago‐miR‐
124 cluster (red line) according to their expression indicated as log2 ratio
(normalized probe intensity vs median probe intensity (771)), showing that low
abundance transcripts are recovered less efficiently by Ago HITS‐CLIP.

B.

Distribution of mRNA tags from Ago HITS‐CLIP (blue line) and Nova HITS‐
CLIP (red line) according to their length. Sequence data from 454 sequencing (B)
or Solexa/Illumina genome analyzer (C) are plotted. Distinct peaks in the
distributions are marked by arrows.
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Figure 7.1
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Figure 7.2. Models of interplays between RNABPs and Ago‐miRNA complexes

A. A model of competitive bindings between an RNABP and an Ago‐miRNA
complex. An RNABP‐RNA interaction may inhibit Ago‐miRNA from binding to
an adjacent miRNA target site through steric hindrance. Therefore, the RNABP
binding can protect the target transcript from miRNA‐mediated repression. In
RNABP null cells, more Ago‐mRNA CLIP tags in the target site and enhanced
miRNA mediated target repression are expected to be shown as indicated as box.
B. A model of cooperative bindings between RNABPs and Ago‐miRNA
complexes, showing increased local concentration of Ago‐miRNA complexes by
RNABPs and subsequent Ago termary complex formation. If RNABPs can
interact with Ago‐miRNA complexes, binding of RNABPs to their interacting
sites (high affinity bindings), adjacent to miRNA target sites, may increase the
local concentration of Ago‐miRNA complexes and facilitate their binding to the
miRNA target sites (low affinity binding). C. The same cooperative model with
different mechanisms. Secondary structure of an RNA transcript may hinder the
access of Ago‐miRNA complex to its miRNA binding site. The binding of an
RNABP to the same transcript may refold the target RNA into the structure
releasing a miRNA binding site. In addition, a neighboring RNA associated
RNABP may further activate Ago‐ternary complex. In RNABP null cells, less
Ago‐mRNA CLIP tags in the target site and less effect from miRNA mediated
repression are expected to be shown. D. A model showing that an RNABP
binding to Ago ternary complex can switch a miRNA‐mediated target regulation
from repression to activation. In the presence of an agonistic RNABP, more Ago‐
mRNA binding in the target site would lead to increased miRNA mediated
translational acitivation.
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